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This thesis is divided into two parts. Part I is focused on the asymmetric 
synthesis of six-membered N-heterocyclic rings mediated by bifunctional thiourea 
catalysts. In addition, Part II describes the exploration of DNA cleavage activities by 
certain small organic molecules. 
In chapter 1, a brief historic overview of asymmetric organocatalysis was 
provided and different types of catalysts were introduced. In particular, bifunctional 
thiourea catalysts based on cinchona alkaloids were discussed in detail. A selection of 
examples and the reaction mode of hydrogen bonding interaction were shown in this 
chapter to highlight the recent development in this field and emphasize the advantages 
of using this type of catalysts. 
In Chapter 2, chiral 3-nitro-1,2-dihydroquinolines were synthesized catalyzed by 
cinchona alkaloids based bifunctional thiourea catalysts. A cascade reaction was 
successfully introduced to react between N-(2-formylphenyl)benzenesulfonamide and 
nitrooelfin. Installation of suitable electron withdrawing groups on the amino moiety 
could enhance the reactivity and improve the enantioselectivity of the reaction. The 
desired compounds were achieved in high yields and with up to 90% enantiomeric 
excesses. These six-membered N-heterocyclic rings were proved to be quite useful in 
the pharmaceutical industry and medicinal chemistry. 
In Chapter 3, Chiral 2-Aryl-2,3-dihydroquinolin-4(1H)-ones, as an another class 
of six-memebered N-heterocyclic rings, were synthesized through a intramolecular 
 viii 
cyclization reaction catalyzed by quinidine-derived tertiary amine-thiourea catalyst. 
The resulting compounds were obtained followed by decarboxylation and 
desulfonylation reaction. The yields were high and the enantioselectivities could 
research to 98%. These 2-substituted dihydroquinolinones were proved to be  
valuable precursors for diversified medicinal compounds. 
Chapter 4 described the synthesis of two classes of sufur-containing cyclic 
organic compounds. For disulfide-derived Beaucage‟s reagent analogue, 
aminomethylated Beaucage‟s reagent and its sulfoxide analogue were successfully 
synthesized. And for trithiol-derived cyclic organic compounds, varacin B were 
successfully synthesized. All the compounds synthesized were used to explore the 
DNA-cleaving activities and all of them showed the good effectiveness in converting 
circular supercoiled DNA to the corresponding circular nicked form. 
In chapter 5, a new selected oligonuleotide was discovered to perform a site 
specific cleavage reaction based on guanine quadruplex structure catalyzed by the 
combination of Mg
2+
 and histidine. Different methods, such as: CD spectrum, PAGE, 
middle phosphorus (
32
P) labeling, were used to prove this cleavage reaction occurred 
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Chapter 1 Introduction 
1.1 Asymmetric Organocatalysis 
As an important element in nature, the chiralty of the molecular has been 
attracted much more attention in the pharmaceutical industry as well as in the other 
industries, such as: semiconductor industry and food industry.
1
 Compounds with one 
or more chiral centers but determined as one single enantiomer usually show unique 
physical properties and biological activities. For example, one third of all sale drugs 
around the world are represented as the chiral molecules and the research conducted 
by FDA has shown that that the enantiomeric pure drug candidates could provide 
better therapeutic effect and less side effect over the racemic mixtures of the drug 
candidates.
2-3
 So the asymmetric synthesis of optical pure molecules is on demand 
these days. 
The development of efficient methods to obtain the chiral compounds is 
becoming the great challenge for organic chemists. Historically, these chiral 
compounds could obtained either by chemical transformation of chiral precursors or 
by kinetic resolution of the racemic mixtures. However, both methods have their own 
drawbacks. The former one requires suitable precursors and the latter one can only get 
50% of the desired products theoretically.  
Compared to these two methods, asymmetric catalysis shows great significance 
because according to this method, many new chiral products could generated only by 
introducing chiral catalysts and many versatile chiral sources could be act as chiral 




The types of asymmetric catalysis could be mainly divided into three categories.
5
 





 However, the metal mediated catalysis usually requires the 
combination of the chiral ligand and the transition metal. The transition metals are 
usually toxic, expensive, easily contaminated and the reaction conditions are quite 
harsh and restricted with moisture and oxygen.
45
 For the biocatalysis, because of the 
highly selectivity of the enzyme, the reaction type and substrates are quite narrow. 
 Until recently, the third discipline of asymmetric catalysis: asymmetric 
organocatalysis, has becoming new and hot area. In asymmetric organocatalysis, the 
chiral organic molecules are acted as the catalytically activated species. The 
advantages of organocatalysts are significant: they are metal free, nontoxic, readily 
available and different organocatalysts can promote various types of reactions through 
different activation modes. 
The concept of “organic catalyst” was first introduced by Otswald in 1900, 
which was used to differentiate the organic molecules as catalyst from that of 
enzymes and other molecules involving the metals.
46
 After that, the first example of 
an asymmetric reaction was reported by Bredig and the reaction was as following: 
The hydrocyanation reaction of benzaldehyde was catalyzed by natural cinchona 
alkaloids quinine 1 and quinidine 2 to give the product 3a and 3b.
47
 Although the 
enantioselectivities of these reactions were very poor, this was still memorialized as 
the pioneer work in the field of organocatalysis. Another example of an asymmtric 
reaction in the early stage was that in the late 1950s, Pracejus reported the addition 
 3 
reaction of methanol to methyl phenyl ketene by using O-acetyl-quinine 4 as catalyst 
to obtain the product 5 in 74% ee.
48
 However, the field of organocatalysis did not 
enormous developed until the last decade of the twentieth century, only few examples 
were reported such as proline-catalyzed asymmetric annulation 
49-50
 and 
phase-transfer catalyzed asymmetric alkylation reactions.
51-53
 Around the turn of the 
century, MacMillan coined the term “organocatalysis” and over the last few years 
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1.2 Hydrogen Bonding Mediated Asymmetric Catalysis 
1.2.1 Introduction 
Hydrogen bonding is one of the most powerful forces in molecular interaction 
and recognition in the biological system.
60
 It is responsible for forming various 
structures, like the ability of proteins to fold the three dimensional structures; the 
match of DNA base paring; the binding of ligands to acceptors. This unique 
noncovalent interaction is not only important to the structure determination, but also 
crucial in catalysis. For a very long time, scientists have tried much effort to design 
the small molecules that mimic the activities of enzymes. However, because lacking 
of the rigid and three dimensional structures as well as the functional groups in the 
molecules, the design was always facing the huge challenge. Over the four decades, 
the main strategy of enantioselective catalysis has involved the electrophile activation 
by metal-cenrtered chiral Lewis acids.
61
 The supramolecular complex matches the 
sophistication of enzyme thus catalyzing enantioselective transformation.
62 
However, 
the development of chiral Brønsted acids as activation forces is highly challenging 
because the hydrogen bonding interactions between promoter and substrates are quite 
weak. Recently, organic chemists have begun to appreciate the great potential by 
hydrogen bonding as a mechanism for electrophile activation in the small, synthetic 
catalyst system.
63-64
 This type of catalysis is complementary to the existing Lewis acid 




According to the different activating modes of hydrogen bonding and various 
 5 
scaffolds of the chiral sources, these catalysts will be classified into three catagories: 
Chiral diol-based organocatalysts, Chiral Phosphoric acids and Urea and thiourea 
catalysts. They will be introduced individually in this chapter. 
 
1.2.2 Chiral Diol-Based Organocatalysts 
As early as in the 1980s, the first examples of biphenylenediol-accelerated 
epoxide aminolysis and Diels-Alder reaction were reported to demonstrate that chiral 
diols could not only act as good ligands in the enantioselective Lewis acid mediated 
reaction, but also perform well as general acid catalyzed asymmetric reactions 
(Scheme 1-2).
70-72 
This is consistent with the computational study by Jørgensen who 
proposed that the water could coordinate the carbonyl group in the substrate to 


















6a: R = H
6b: R = NO2
7
8  
Scheme 1-2 Biphenylenediol-accelerated epoxide opening and cycloaddition 
reactions 
 
From initial study, α,α,α‟,α‟- tetraaryl-1,3-dioxolane-4,5-dimethanol (TADDOL) 
derivatives and 1,1‟-bi-2-naphthol (BINOL) became effective catalysts. The pioneer 
work of TADDOL derivatives was done by Toda and co-workers. They discovered 
that these derivatives are efficient resolving agents for numbers of the basic species 
 6 
through the formation of H-bonded inclusion compounds.
75-77
 For example, TADDOL 
10 and diene 9 could react in the UV condition to result [2+2] cycloaddition product 



















11 > 99% ee
    99% yield








Scheme 1-3 Enantioselective solid-state photochemical [2 + 2] cycloaddition 
 
Another example catalyzed by TADDOL was asymmetric hetero-Diels-Alder 
reaction of aminodienes with aldehydes in the presence of the 10 mol% 12. This was 
the first successful application of chiral diol as hydrogen bonding catalyst. This 





















12: Ar = 1-Np
10 mol% 12
toluene, - 60 oC
+
13: 83% ee
      67% yield
 
Scheme 1-4 Enantioselective hetero-Diels-Alder reaction by catalyst 12 
 
 7 
Subsequent research revealed that electrophiles rather than aldehydes may also 
be actived by catalyst 12. The asymmetric aldo reaction of enamines could occur by 












12: Ar = 1-Np
10 mol% 12









 14: 83% ee, 81% yield
+
 
Scheme 1-5 Enantioselective aldo reaction of enamines 
 
For BINOL structure, numbers of applications were found by optimizing the 
binaphthol scaffold. The ability of this structure to act as chiral hydrogen bond donor 
was found by McDougal and Schaus in the enantioselective Morita-Baylis-Hillman 
reactions. Arene-substitued octahydro (BINOL) derivatives such as catalyst 15 could 
afford the product 16 with high enantioselectivities. And another (BINOL) derivative 
17 was found to catalyze the aza-Morita-Baylis-Hillman reaction. This catalyst played 
as bifunctional catalyst, in which phenol hydroxyl groups activated the electrophile 











































Scheme 1-7 Enantioselective aza-Morita-Baylis-Hillman reaction 
 
1.2.3 Chiral Phosphoric Acids   
Chiral phosphoric acids derived from binaphthols have been proved to be useful 
in molecular recognition applications. In 2004, Akiyama 
80
 and Terada 
81
 groups 
independently reported the ennatioselective Mannich reaction catalyzed by 
phosphoric acids. Their researches showed that these catalysts had strong acidic 
 9 
proton and could form highly ionic hydrogen bonds. The enantioselectivities were 






































19a: R = p-NO2Ph
19b: R = 4-(2-Np)-C6H4
 
Scheme 1-8 Ennatioselective mannich reaction catalyzed by phosphoric acids 
 
Chiral Phosphoric acids could also catalyze the aza-Friedel-Crafts reaction. The 







 These reactions were catalyzed by chiral phosphoric acids 












(R) 20a: Ar = 4-NO2CH4
(R) 20b: Ar = 4-β-naphthyl-C5H4
(R) 20c: Ar = 4-ClC6H4
(R) 20d: Ar = 3,5-dimesitylphenyl
(R) 20e: Ar = 9-anthryl
(R) 20f: Ar = SiPh3
(R) 20g: Ar = 2,4,6-(iPr)3C6H2
(R) 20h: Ar = 3,5-(CF3)2C6H3
(R) 20i: Ar = 9-phenanthryl






Scheme 1-9 Enantionselective aza-Friedel-Crafts reactions catalyzed by chiral 
phosphoric acids 
 
The List group 
89
 and MacMillan 
90
 group first independently developed the 
asymmetric hydrofenation reaction by employing Hantzsch esters as hydride source 
for the reduction of imines and chiral phosphoric acid as chiral inducer. The yields 















21a: R1 = Me, R2 = iPr, R3 = R4 = Me
21b: R1 = R2 = Me, R3 = R4 = Et
22
 
Scheme 1-10 Enantionselective hydrofenation reaction 
 
With the realization of strong activation ability of Brønsted acids with imines, 
the resulting imines could naturally participate in the aza-Diels-Alder reactions with 
electron-rich dienes. Akiyama et al. developed the catalyst 20k for the asymmetric 
 12 
aza-Diels-Alder reaction of aldimines with vinyl ethers.
91
 The OH motif of the 
aldimine was found to be crucial for attaining the enantioselectivities and yields in the 

























Scheme 1-11 Enantionselective aza-Diels-Alder reaction of aldimines with vinyl 
ethers 
 
Terada et al. demonstrated an enantioselective azaene-type reaction between 
N-acylimines and enamides catalyzed by chiral phosphoric acid to obtain the 























Scheme 1-12 Enatioselective aza-ene-type reaction catalyzed by (R)-20e 
 
 13 
Gong‟s group reported the three component Biginelli reaction of ketoesters, 
thioureas and aromatic aldehydes catalyzed by chiral phosphoric acid 24 to give the 





Scheme 1-13 Enatioselective three-component Biginelli reaction 
 
1.2.4 Urea and Thiourea Catalysts 
1.2.4.1 Monofunctional Urea and Thiourea Catalysts 
The concept that urea and thioureas can function as catalysts by activation of 
electrophiles through double hydrogen bonding interaction has been explored by 
many research groups. The pioneer work was done by Etter‟s group and Curan‟s 
group. Etter and co-workers demonstrated that electro-poor diaryl ureas 27 could be 
cocrystallized with numbers of Lewis basic molecules by the formation of double 
hydrogen bonds.
94-95




























Scheme 1-14 Claisen rearrangement catalyzed by diaryl urea 28 
 
However, the utilization of different urea and thiourea as viable catalysts came 
from the work of Jacobsen. A series of Schiff bases derived from urea and thioureas 
were synthesized, which were originally designed as potential ligands for 
organometallic catalysis. They surprisingly found that thiourea effectively catalyzed 
the Strecker reaction without involving the metal. As a result of the library synthesis, 









R1 = aryl, alkyl
R2 = H, Me
R3 = aryl, alkyl, heteroatom





















Scheme 1-15 Enatioselective reaction of aldimines and methylketoimines with HCN 
 
An enantioselective and catalytic acyl-Pictect-Spenger reaction using thiourea 
catalyst 32 was also developed by Jacobson group. The catalyst here not only 
represented the first example of asymmetric catalysis of this heterocycle forming 
reaction, but also demonstrated that N-acyliminium ions could be activated by chiral 





























Scheme 1-16 Enatioselective acyl-Pictect-Spenger reaction 
 
Nagasawa reported the use of chiral diaryl thiourea 34 to catalyze the 
 16 
asymmetric Morita-Baylis-Hillman addition of cyclohexenone 35 to a range of 
activated aldehydes.
101
 The high enantioselectivities were assumed to be the hydrogen 























Scheme 1-17 Enatioselective Morita-Baylis-Hillman addition of cyclohexenone to 
aldehydes 
 
The urea and thiourea are considered as a useful class of catalysts because of 
their effect to enantioselective reactions of numbers of nucleophilic and electrophilic 
partners. In addition, thay are both easily prepared and tunable. They are readily 
available to prepare bifunctional catalysts by using amine coupling to introduce 
another acidic or basic group. 
 
 
1.2.4.2 Bifunctional Urea and Thiourea Catalysts 
 
The development of chiral catalysts which could simultaneously activate both 
electrophile and nucleophile is always under investigation. Much pioneer work in this 
field had involved Lewis acid together with additional Bronsted or Lewis basic 
functionality. A hydrogen bond donor (Brønsted acid) is used to activate the 
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electrophile, while a Lewis base is used to activate the nucleophile. Such bifunctional 
catalysts imitate the natural enzymetic system and potentially improve the catalytic 
activity and enantioselectivity.
102-104
 In this section, the early development of chiral 
urea and thiourea based bifunctional catalysts will be discussed and they are classified 
into three categories based on the chiral frameworks where they are derived. 
 
1.2.5 Chiral Cyclohexane Diamine Based Bifunctional Thiourea catalysts 
A novel bifunctional tertiary amine thiourea catalyst was designed by Takemoto 
and co-workers.
105-106
 Catalyst 37 was assembled on the same chiral framework of 
1,2-trans diamine which Jacobsen used. It could successfully catalyze the Michael 
addition of malonate esters to nitro olefins 38. In this dual activation mode shown in 
Figure 1-1, the nitro olefin interact with the thiourea moiety via double hydrogen 
bonding, thus enhance the electophilicity of the reacting carbon. At the same time, the 
tertiary amine part could fix the malonate to the activated enol form.  
 




















Figure 1-1 Dual activation mode of hydrogen bonding interaction of catalyst to 
malonate ester and nitro olefin 
 
Further more, this bifunctional catalyst could extend to catalyze diverse 
asymmetric conjugate addition of thiols with enones,
107
 malononitrile to 












Conjugate addition of thiols with enones





























Scheme 1-19 Selective examples of asymmetric conjugate addition reactions 
 
Later, Takemoto and co-workers developed new bifunctional aminol thiourea 43 
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for the Petasis reaction of quinolines with vinyl boronic acid.
110
 The 1,2-amino 
alcohol moiety in catalyst 43 was proved to be quite important in the reaction process 
to increase the reactivity and improve the enantioselectivity. It was proposed that the 

































Scheme 1-20 Enatioselective Petasis reaction of quinolines with vinyl boronic acid 
 
Berkessel et al. reported that catalyst 43 could efficiently undergo dynamic 
kinetic resolution of azalactones to give chiral α-amino acids.111 In this reaction, it 
was proposed that the substrate was binding to the catalyst followed by general 
catalysis of ring opening reaction. And they also successfully extend this strategy for 

















43 (5 mol%), PhMe
rt, 48 h
 




















Figure 1-2 Activation mode of catalyst to azalactones 
 
Chen and co-workers demonstrated the Mannich reaction could occur between 
dicyanoolefins and N-Boc benzaldimine catalyzed by catalyst 37 with high yield and 
ee values.
113


















1.2.6 Chiral Napthyl-Derived Bifunctional Thiourea catalysts 
Chiral axial binaphthyl is another class of important scaffold and it is usually 
used in the organometallic reaction as ligands.
114 
Wang and co-workers designed a 
new chiral binapthyl-derived bifunctional thiourea catalyst 48 incorporation with 
thiourea moiety into the chiral binapthyl framework. It worked at the 




 Although the aromatic amine in catalyst 48 seemed weaker as 
nucleophile than aliphatic amines, it showed better result in this reaction compared to 
the Takemoto catalyst 37. 
This organocatalyst could also use in the Michael reaction of 1,3-diketone with 
nitro olefins. The catalyst loading could decrease to 1 mol% and the Michael adduct 
could be readily converted into α-substituted β-amino acids.116  
 
 
Scheme 1-23 Enantioselective Morita-Baylis-Hillman and Michael addition reaction 
catalyzed by catalyst 48 
 
 
1.2.7 Cinchona Alkaloid -Derived Bifunctional Thiourea Catalysts 
Cinchona alkaloids and their derivatives have shown great utilities in asymmetric 
organocatalysis. In the following sections, more information about cinchona alkaloids 
and their derivatives will be introduced and the representative reactions catalyzed by 
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cinchona alkaloid - derived bifunctional thiourea will also be listed accordingly. 
Cinchona alkaloids are natural organic molecules isolated form the bark of 
several species of cinchona trees.
117
 They have played important medicinal role for 
over 300 years. They could be used as an important antimalarial drug and muscle 
relaxant compounds. Cinchona alkaloids were first discovered as resolving agents by 
Pasteur in 1853.
118
 Besides the resolution process, they can also be used as 
enantioselective analytical tools. The stereoselective syntheis of quinine 150 years 
ago laid the foundation of modern organic chemistry. However, the most interesting 
application of Cinchona alkaloids relied on their ability to promote enantioselecitve 
transformation in asymmetric catalysis.  
The first asymmetric reaction carried out by cinchona base was reported by 
Bredig and Fiske in 1912.
119  
They reported the addition of HCN to benzaldehyde in 
the presence of quinine and quinidine. However, the enantioselectivities were in the 
range of 10% ee. Four decades later, Pracejus obtained the useful enantioselectivities 
(74% ee) by using O-acetylquinine in the reaction of methanol to 
phenylmethylketene.
120
 In 1981, a landmark research was done by Wynberg and 
co-workers to demonstrate that cinchona alkaloids catalyzed the addition of 
thiophenols to cyclic enones.
121
    
This reaction made researchers to realize that the catalysts could act 
bifunctionally which was dependent on the presence of both tertiary amine part and 
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Scheme 1-24 Bifunctional alkaloid-mediated catalysis reported by Wynberg 
 
The readily available and inexpensive cinchona alkaloids can be classified into 
two sets of pseudoenantiometic pairs: quinine and quinidine or cinchonine and 
cinchonidine. They are now privileged chiral catalysts in the area of asymmetric 
organocatalysis. The key feature which is responsible for the successful catalysts is 
that the chiral skeletons are versatile and tunable for different types of reactions. The 
quinuclidine nitrogen is acted as the chiral base to activate the nucleophilic reaction. 
The secondary 9-OH group can serve as an acid site or hydrogen bond donor. It can 
also be derivatized in to ureas or amides to provide a more powerful acidic site or 
hydrogen bond donors. The 6‟-methoxy group of quinine and quinidine can also be 
derivated to the free OH group or thiourea moiety, which can serve as an effective 
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Figure 1-3 Chemical information and variation of cinchona alkaloids 
 
The first example came from Chen and co-workers who found catalyst 61 and 62 
could catalyze the Michael addition of thiophenol to α, β-unsaturated imide 59, but 





























61 ee: 7% 62 ee: 17%
 
 
Scheme 1-25 The first example of thiourea-substituted cinchona alkaloid mediated 
catalysis 
 
After that, the Soόs and co-workers developed quinine and quinidine derived 
thiourea catalyst 63-65 for the enantioselective addition of nitromethane to chalcones. 
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Long time was necessary to achieve the satisfied yields and the lower catalyst loading 





































64a: R = CH=CH2, ee: 95%
64b: R = CH2CH3, ee: 96%
65, ee: 86%
 
Scheme 1-26 Asymmetric catalysis of the addition of nitromethane to chalcone 
 
The Dixon‟s group reported the cinchonine derived catalyst 62 to catalyze the 
reaction of malonate ester to nitro olefin at -20 
o




Scheme 1-27 Enantioselective reaction of malonate ester to nitro olefin 
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Inspired by the pioneer work by successfully using cinchona alkaloid derived 
organocatalyst in the asymmetric catalysis, remarkable numbers of the reactions were 
explored by several other researchers. 
Ricci and co-workers first proved the catalyst 64a could successfully catalyze the 
aza-Henry reaction between nitromethane and N-Boc imnine which was derived from 
benzaldehyde. Other carbamate protecting groups gave the similar results.
125
  
In a similar study, Schaus and co-workers used the catalyst 64b to catalyze the 
same reaction class with methylcarbamate derivatives and large excess of 




Scheme 1-28 Modified cinchona alkaloid catalyzed aza-Henry reaction 
 
An asymmetric Mannich reaction was also explored by researchers. Dixon‟s 
group demonstrated that acetyl actone, malonate esters and β-ketoesters could take 





Scheme 1-29 Enantioselective Mannich reaction by catalyst 64 
 
Shortly after that Deng‟s group 128 and Schaus‟s group reported the similar results 
by using quinine and quinidine derived catalyst analogues. For Friedel-Crafts-type 
reaction, Deng‟s group firstly reported the asymmetric synthesis of 3-indolyl 
methanamine subunit from indoles and imines by using catalyst 64a.
129
 
The high enantioselectivity were observed no matter of the electronic character 
of the substrates. This study was the first example to participate the alkyl imines in the 
selective Friedel-Crafts-type reaction. 
 
 
Scheme 1-30 Enantioselective Friedel-Crafts-Type reactions with imine substrates 
Other reactions, such as: Diels-Alder reaction,
130
  Decarboxylation reaction
131 
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and desymmetrisation of meso anhydrides,
132
 because of the constraint of the text, 
they will not listed in details in this chapter.   
 
1.3 Project Objective 
Since the cinchona alkaloids derived bifunctional thiourea catalysts have been proved 
to quite useful in the field of asymmetric organocatalysis, the purpose of our study is 
to design and synthesize the novel bifunctional thiourea catalyst in the asymmetric 
synthesis of six-membered N-heterocycles which have been found in biologically and 
medicinally important natural products. The next two chapters will focus on the 
asymmetric synthesis of two different types of six-membered N-heterocycles: 
Hydroquinolines and Dihydro-4-quinolones through two different methodologies. 
Chapter 2 will introduce how to synthesis of hydroquinolines by a cascade 
aza-Michael-Henry-dehydration reaction. In addition, chapter 3 is going to provide an 
efficient method to symmetric synthesis of chiral dihydro-4-quinolones through 













Chapter 2 Bifunctional Thiourea Catalyzed Cascade Reaction: 
Asymmetric Synthesis of 3-nitro-1,2-dihydroquinolines 
 
2.1 Introduction 
The functionalized six-membered heterocycles containing one nitrogen atom 
have been found quite important in biology and medicinal chemistry. Among these 
nitrogen heterocycles, hydroquinolines can be considered as a class of substrates 
which represent the most frequently encountered ones in natural or synthetic 
products.
133-135
 It possess a broad spectrum of biological activities, are of great 
importance in pharmaceutical industry and medicinal chemistry. Some scaffolds 
containing the hydroquinolines cores have showed antimicrobial activity against 
fungal and bacterial species.
136
 In particular, functionalized 1,2-dihydroquinolines are 
useful structural motifs and synthetic intermediates in natural product synthesis.
137-138
  
Methods for the catalytic asymmetric synthesis of chiral 1,2-dihydroquinolines 
are very limited. Most literatures reported the synthesis of non-catalytic asymmetric 
synthesis of chiral 1,2-dihydroquinolines.
139-143
 Shibasaki and co-workers developed 
an asymmetric Reissert-type reaction promoted by a Lewis acid-Lewis base 


















2-1a: X = H, Y = H
2-1b: X = OCH3, Y = H
2-1c: X = N(CH3)2, Y = H
2-1d: X = Y = OCH3
2-1e: X, Y = OCH2O
2-1f: X = Cl, Y = H







Scheme 2-1 Asymmetric Reissert-type reaction 
 
Wang et al. disclosed an asymmetric synthesis of 3-formyl-1,2-dihydroquinolines 
employing a domino conjugate addition-aldol-dehydration reaction promoted by 












P = Cbz or Ts










98% yield, 96% ee
20 mol%
 
Scheme 2-2 Enatioselective domino conjugate addition-aldol-dehydration reaction 
 
A similar approach for the dihydroquinoline synthesis was independently 
reported by Cόrdova and co-workers.146 The highly enantioselective organocatalytic 
cascade reaction is presented between 2-aminobenzaldehydes and a,b-unsaturated 
aldehydes proceed with excellent chemo- and enantioselectivity to give 





















Scheme 2-3 Asymmetric domino reaction reported by Cόrdova 
 
Given the importance of functionalized 1,2-dihydroquinoline compounds, and 
lack of efficient method for the preparation of chiral 3-nitro-1,2-dinhydroquinolines, 
developing an organocatalytic approach to tackle this synthetic problem became a 
challenge. From the first chapter, bifunctional organic molecules containing a tertiary 
amino group and a thiourea moiety have been established as remarkably useful 
organic catalysts. And inspired by other researchers‟ work, the cascade reaction has 
been chosen as a suitable method to synthesis of chiral 3-nitro-1,2-dinhydroquinolines. 
It is characterized by the efficiency and its biomimetic way, because the same 
principles are found in the biosynthesis of nature products. 
147-149 
Cascade reactions 
avoid the time-consuming and protection/deprotection processes and they usually 
come out the products with multiple stereocenters and excellent steroselectivities. In 
addition, they are environmentally friendly. Because of these advantages, cascade 
reactions become flourishing in organic chemistry over classical synthesis. 
In fact, some examples of cascade reactions by bifunctional thiourea catalyst 
have been successfully explored. For example, Takemoto and co-workers reported the 
cascade Michael–Michael reaction of γ,δ-unsaturated β-ketoesters with nitroolefin 
catalyzed by amine thiourea 37 (Scheme 2-4).
150
 The process gave products in high 
 32 
yields (62–87%) and with high enantio- (84–92% ee) and diastereoselectivities (d.r. 
82:18–>99:1). However, the addition of a base (TMG or KOH) was essential for the 


























Scheme 2-4 Asymmetric Michael-Michael reactions catalyzed by catalyst 37 
 
Wang and co-workers recently reported a powerful 64a catalyzed cascade 
thiol-Michael – aldol reaction of 2-mercaptobenzaldehyde with α,β-unsaturated 
oxazolidinone.
151
 The products 2-6 had three stereogenic centers in excellent 
stereoselectivity which may be attributed to the noncovalent hydrogen-bonding 











































Figure 2-1 Activation mode of cascade thiol-Michael–aldol reaction 
 
Later on, the same group developed a new cascade Michael-Michael reaction 
catalyzed by 64a between the ethyl with a range of nitroalkenes to afford the 































90%, 97% ee 99%, 97%ee 88%, 97% ee 90%, 99% ee
Scheme 2-6 Asymmetric cascade Michael-Michael reactions catalyzed by catalyst 
64a 
 
The quinidine-derived thiourea catalyst 62 was also applied to the aldol addition 
of the α-isothiocyanato imide to benzyladehyde to afford the mixture of 
thiooxazolidinones 2-8a and 2-8b.
153 
 
Scheme 2-7 Asymmetric aldol addition of the α-isothiocyanato imide to 
 35 
benzyladehyde 
Inspired by these pioneer work of cascade reactions and the successfully reported 
of racemic synthesis of 3-nitro-1,2-dihydroquinoline,
154
 a chiral version of synthesis 
of 3-nitro-1,2-dihydroquinoline catalyzed by cinchona alkaloids derived bifunctional 
thiourea catalyst through a cascade reaction seems reasonable and practical.  
We envisage that a cascade process mediated by tertiray amine-thiourea catalyst 
can lead to a one-pot generation of chiral 3-nitro-1,2-dihydroquinoline (Figure 2-2). 
Installation of an electron-withdrawing group on the amino moiety of 
2-aminobenzaldehyde is anticipated to render aniline N-H increased acidity, the 
abstraction of which by the tertiary amine leads to an aza-Michael reaction. The 
thiourea group in the chiral catalyst is anticipated to have hydrogen bonding 
interactions with the nitro group. The subsequent Henry reaction with the aldehyde, 















2.2 Result and Discussion 
 
2.2.1 Catalyst and Solvent Screening 
In this reaction, sulfone was used to activate the amino group, and the reaction 
between N-(2-formylphenyl)benzenesulfonamide and nitrooelfin was chosen for the 
initial exploration.  
As cinchona alkaloids are well-established powerful organic catalysts, a number 
of cinchona alkaloid-based organocatalysts were examined in our study.  
From the result of catalysts screening, quinine-derived 2-12 and quinidine 2-13 
effectively promoted the projected cascade reactions, yielding the desired 
3-nitro-1,2-quinolines in excellent yields, albeit in poor enantioselectivites (entries 1 
and 2). Quinidine-derived sulfonamide 2-14 was completely ineffective (entry 3). 
While quinidine-derived thiourea catalysts 2-15, 2-16 and 2-17 offered low 
enantioselectivities (entries 4-6). However, thiourea 2-18 was found to be a good 
catalyst, affording the desired quinoline in moderate enantioselectivity (entry 7).  
Enantioselectivity was substantially improved when toluene was used as the 
solvent (entry 8). Electron-withdrawing sulfone group in the sulfonamide substrate is 
essential for the observed reactivity, as no reaction was observed when 
2-aminobenzaldehyde or its N-Cbz-protected derivative was used. It suggested that 
sulfonamide moiety in the substrate might play an important role in asymmetric 
induction, thus various sulfonamides were prepared and their influences were 
investigated.  
Mesylate afforded the product in high yield, but the enantioselectivity was 
 37 
significantly decreased, suggesting that the steric hindrance of the sulfonamide may 
be important in the asymmetridc induction (entry 9). Sulfonamides containing various 
electron-withdrawing groups on the phenyl rings or naphathylene gave results 
comparable to those obtained with tosylsulfonamide (entries 10 to 13). By employing 
sterically hindered 2,4,6-trimethylbenzenesulfonamide substrate, very good 
enantioselectivity was attainable (entry 14). Using more hindered 
2,4,6-triisopropylbenzenesulfonamide led to further improvement in the 
enantioselectivity of the reaction. Under the optimized reaction conditions, the desired 
3-nitro-1,2-dihydroquinoline was obtained in 81% yield and with 90% ee (entry 16). 
 






















































































1 2-12 Ts CH2Cl2 12 95 13 
2 2-13 Ts CH2Cl2 48 95 12 
3 2-14 Ts CH2Cl2 73 - - 
4 2-15 Ts CH2Cl2 24 95 23 
5 2-16 Ts CH2Cl2 48 70 15 
6 2-17 Ts CH2Cl2 50 80 9 
7 2-18 Ts CH2Cl2 50 95 48 
8 2-18 Ts Toluene 72 95 70 
9 2-18 Ms Toluene 48 95 40 
10 2-18 pCF3-Ph Toluene 72 43 63 
11 2-18 pNO2-Ph Toluene 72 79 58 
12 2-18 3,5-CF3-Ph Toluene 18 > 95 55 
13 2-18 1-naphthyl Toluene 72 > 95 72 
14 2-18 2,4,6-Me-Ph Toluene 60 80 86 
15 2-18 2,4,6-iPr-Ph Toluene 60 57 90 
16
d 
2-18 2,4,6-iPr-Ph Toluene 72 81 90 
17 2-18 2,4,6-iPr-Ph CH2Cl2 72 60 65 
18 2-18 2,4,6-iPr-Ph Xylene 72 70 86 
19 2-18 2,4,6-iPr-Ph DMF 48 95 0 




 The reactions were performed with 2-9 (0.025 mmol), 2-10a (0.075 mmol) and catalyst (0.0025 





 The ee value was determined by chiral HPLC analysis. 
d
 20 mol% catalyst was used 
 
 
2.2.2 Reaction Scope 
 
This cascade aza-Michael-Henry-dehydration reaction is applicable to different 
nitroolefins (Table 2-2). Various meta- or para-substituted aryl nitroolefines were 
suitable substrates, and the electronic nature of the aromatic rings can also be varied, 
the ee vary from 81% to 90%. In addition, aliphatic nitroolefin could be used (entry 
10) in the condition of increasing the catalyst loading to 50 mol%. Moreover, 
employment of different ortho-formyl anilines easily led to the formation of different 
quinolines (entry 12). However, ortho-substituted aryl nitroolefins were poor 
substrates, the ee could surprisingly drops a lot (entry 13) likely due to the steric 
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repulsion resulted from the nearby bulky sulfonamide group. 
 
Table 2-2 Asymmetric Synthesis of Various 3-Nitro-1,2-dihydroquinolines via 

































1 2-11h H/Ph 72 81 90 
2 2-11i H/4-F-Ph 36 77 82 
3 2-11j H/4-Br-Ph 36 91 85 
4 2-11k H/4-CN-Ph 36 92 87 
5 2-11l H/4-CH3-Ph 48 83 81 
6 2-11m H/4-CH3O-Ph 48 75 84 
7
 
2-11n H/3-Cl-Ph 72 90 87 
8 2-11o H/3-Br-Ph 72 86 89 
9 2-11p H/3-CH3-Ph 72 83 81 
10
 d
 2-11q H/(CH3)2C-Ph 72 86 70 
11
 
2-11r H/2-Naphthyl 72 75 82 
12 2-11s Cl/Ph 72 78 88 
13 2-11t H/2-CH3-Ph 72 60 17 
 
a 
The reactions were performed with 2-9 (0.025 mmol), 2-10 (0.075 mmol) and 2-18 (0.0025 




 The ee value was 
determined by chiral HPLC analysis. 
d
 50 mol % catalyst was used 
 
2.2.3 Synthesis of 3-nitro-1,2-dihydroquinolines 
The sulfonamide group could be easily removed by reductive cleavage. When 
2-11j was treated with magnesium in methanol under reflux, 2-aryl-substituted 
3-nitro-1,2-dihydroquinoline 2-11’j was obtained in good yield. It should be noted 
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that the enantioselectivity was maintained and the bromine atom on the benzene ring 
















Scheme 2-8 Cleavage of sulfonamide group 
 
2.3 Conclusion 
The examples described above have successfully demonstrated that the power of 
cascade reaction catalyzed by cinchona alkaloids derived bifunctional thiourea 
catalyst. These cascade reactions have provided new and efficient approaches to 
construct the complex chiral molecules from simple achiral substrates. For the 
cascade aza-Michael-Henry-dehydration reaction developed by our group, it was 
demonstrated the efficient preparation of chiral 3-nitro-1,2-quinolines which were 
quite important and useful in the medicinal chemistry. By installing an 
electron-withdrawing sulfone group on anilines, the substrates could be activated by 
well-established tertiary amine-thiourea catalysts, and this strategy may find wide 
applications in the preparation of nitrogen-containing heterocycles.  
Mechanistic understanding of this cascade reaction, development of other 
organocatalytic cascade processes and their applications to the asymmetric synthesis 
of flavonoids and their structural analogues are currently in progress. 
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2.4 Experimental Section 
    
2.4.1 General Information 





C NMR spectra were recorded on a Bruker ACF300 or DPX300 
(300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in 
parts per million (ppm), and the residual solvent peak was used as an internal 
reference: proton (chloroform  7.26), carbon (chloroform  77.0). Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz 
(Hz). Low resolution mass spectra were obtained on a Finnigan/MAT LCQ 
spectrometer in ESI mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB 
mode and mass spectrometer in EI mode. All high resolution mass spectra were 
obtained on a Finnigan/MAT 95XL-T spectrometer. For thin-layer chromatography 
(TLC), Merck pre-coated TLC plates (Merck 60 F254) were used, and compounds 
were visualized with a UV light at 254 nm. Flash chromatography separations were 
performed on Merck 60 (0.040 - 0.063 mm) mesh silica gel.  
Different sulfonamide-containing 2-aminobenzaldehydes were synthesized 
according to the literature procedure,
155
 and the thiourea catalysts were prepared 









2.4.2 Representative Procedures 





























Scheme 2-9 Cascade aza-Michael-Henry-Dehydration reaction by catalyst 2-18 
 
A solution of N-(2-formylphenyl)-2,4,6-triisopropylbenzenesulfonamide 2-9h 
(9.7 mg, 0.025 mmol), (E)-(2-nitrovinyl)benzene 2-10 (11.2 mg, 0.075 mmol) and 
thiourea 2-18 (2.6 mg, 0.005 mmol) in toluene (200 L) was stirred at room 
temperature for 72 hrs. The mixture was then diluted with water, and extracted with 
CH2Cl2 several times. The combined organic layers were dried over anhydrous 
Na2SO4. After concentration, the residue was purified by flash chromatographic 
column (EtOAc: Hexanes = 1: 10) to afford 2-11h as a light yellow solid (10.5 mg, 

























Scheme 2-10 Reductive desulfonylation by Mg and MeOH 
 
To a mixture of 2-11j (44.7 mg, 0.075 mmol) and activated Mg (18 mg, 0.75 
mmol) in a 25 mL round bottom flask was added anhydrous methanol (10 mL). The 
reaction solution was brought to reflux overnight. After cooling down to room 
temperature, the reaction mixture was quenched by adding 1 M aqueous HCl, and 
extracted by CH2Cl2 several times. The combined organic layers were dried over 
anhydrous Na2SO4. After concentration, the residue was purified by flash 
chromatographic column (EtOAc: hexanes = 1: 8) to afford 2-11’j as a dark red solid 
(21 mg, 85% yield). 
 
2.4.3 Determination of the Absolute Configurations of Products   
The absolute configuration of 2-11’j was determined by comparing the HPLC 
traces of 2-11’j with those reported in the literature,157 and the absolute configuration 
of 2-11j was deduced accordingly. The configurations of other quinolines were 




















 = 331.9983, found = 331.9989. The NMR spectra of 2-11’j 
were consistent with the literature data.
 
The enantiomers of 2-11’j were analyzed by 
chiral phase HPLC using OD-H column at 254 nm (2-propanol/hexane = 15/85), flow 
rate = 1.0 mL/min; major enantiomer: tR = 19.8 min, minor enantiomer: tR = 15.9 min 
(literature:
3
 major enantiomer: tR = 21.0 min, minor enantiomer: tR = 15.6 min).  
 







A yellow solid; Isolated in 95% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5: 1); 
1
H NMR (300 MHz, CDCl3) δ 2.38 
(s, 3H), 6.90 (s, 1H), 7.11-7.14 (d, J = 8.4 Hz, 2H), 7.28-7.32 (m, 4H), 7.48 (m, 1H), 
7.57 (s, 1H), 7.77-.7.79 (d, J = 8.0 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 21.5, 55.5, 
125.1, 126.6, 126.8, 127.6,128.5, 128.6, 128.7, 128.8, 129.6, 129.8, 132.5, 134.2, 
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134.8, 135.1, 144.0, 144.6. The enantiomers were analyzed by HPLC using an AD-H 
column at 254 nm (2-propanol: hexane = 10: 90), 1.0 mL/min; Major enantiomer: tR = 







 = 429.0880, found = 429.0894. 
                         






A yellow oil; Isolated in 95% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5: 1); 
1
H NMR (300 MHz, CDCl3) δ 2.78 
(s, 3H), 6.88 (s, 3H), 7.25-7.34 (m, 6H), 7.44-7.52 (m, 2H), 7.65-7.66 (d, J = 8.2 Hz, 
1H), 8.15(s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 38.6, 55.7, 124.0, 126.3, 126.6, 127.1, 
128.8, 129.0, 129.2, 130.5, 133.0, 134.4, 135.4, 144.7; The enantiomers were 
analyzed by HPLC using an AD-H column at 254 nm (2-propanol: hexane = 10: 90), 
1.0 mL/min; Major enantiomer: tR = 26.9 min, minor enantiomer: tR = 20.0 min. 


























A yellow solid; Isolated in 43% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1); 
1
H NMR (300 MHz, CDCl3) δ 6.92-6.95 
(m, 1H), 7.27-7.31 (m, 5H), 7.35-7.38 (m, 2H), 7.50-7.62 (m, 6H), 7.79-7.83 (m, 1H); 
13
C NMR (75 MHz, CDCl3) δ 55.7, 121.0, 124.6, 124,9, 125.9, 126.0, 126.1, 126.2, 
126,7, 127.1, 128.0, 128.3, 128.4, 128.8, 129.0, 130.1, 132.8, 133.4, 134.5, 134.9, 
135.4, 141.0, 144.0; The enantiomers were analyzed by HPLC using an AD-H column 
at 254 nm (2-propanol: hexane = 10: 90), 1.0 mL/min; Major enantiomer: tR = 16.0 















A yellow oil; Isolated in 79% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 5: 1 to 3:1); 
1
H NMR (300 MHz, CDCl3) δ 6.91 
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(s, 1H), 7.21-7.27 (m, 5H), 7.34-7.37 (m, 2H), 7.51-7.60 (m, 4H), 7.76-7.79 (d, J = 
7.9 Hz, 1H), 8.15-8.18 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 55.8, 124.1, 124.9, 
126.7, 127.9, 128.2, 128.4, 128.9, 129.1, 130.2, 132.9, 133.1, 134.2, 143.0, 144.0, 
150.4. The enantiomers were analyzed by HPLC using an IA -H column at 254 nm 
(2-propanol: hexane = 10: 90), 1.0 mL/min; Major enantiomer: tR = 54.8 min, minor 
















A yellow solid, isolated in 95% yield; 
1
H NMR (300 MHz, CDCl3) δ 6.92 (s, 1H), 
7.22-7.46 (m, 7H), 7.53-7.61 (m, 2H), 7.80-7.82 (d, J = 1.3 Hz, 2H), 8.05 (s, 1H); 
13
C 
NMR (75 MHz, CDCl3) δ 56.0, 123.7, 124.9, 126.6, 126.7, 126.8, 127.9, 128.4, 128.5, 
128.9, 129.2, 130.2, 132.6, 132.9, 133.0, 133.9, 139.8, 144.0; The enantiomers were 
analyzed by HPLC using an AD-H column at 254 nm (2-propanol: hexane = 2: 98), 
0.5 mL/min; Major enantiomer: tR = 13.3 min, minor enantiomer: tR = 11.6 min. 




 = 528.0578, found = 528.0572. 
 
 








A yellow solid; Isolated in 95% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 7.04 
(s, 1H), 7.23-7.31 (m, 7H), 7.33-7.42 (m, 2H), 7.50-7.67 (m, 3H), 7.78-7.80 (d, J = 
8.5 Hz, 2H), 7.85-7.89 (m, 2H), 8.00-8.01 (d, J = 1.5 Hz, 2H); 
13
C NMR (75 MHz, 
CDCl3) δ 55.6, 121.5, 125.1, 126.7, 127.6, 127.8, 127.8, 128.2, 128.3, 128.4, 128.7, 
128.8, 129.1, 129.2, 129.3, 129.8, 131.7, 132.5, 134.0, 134.6, 134.9, 135.0, 143.9; The 
enantiomers were analyzed by HPLC using an AD-H column at 254 nm (2-propanol: 
hexane = 10: 90), 1.0 mL/min; Major enantiomer: tR = 26.7 min, minor enantiomer: tR 













A yellow solid; Isolated in 80% yield after flash column chromatographic 
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purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 2.32 
(s, 3H), 2.46 (s, 6H), 6.68 (s, 1H), 6.94 (s, 2H), 7.19-7.30 (m, 7H), 7.40-7.43 (m, 2H), 
7.53 (m, 1H), 7.92 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 20.9, 22.3, 54,4, 125.1, 
126.7, 126.9, 128.6, 128.7, 129.0, 130.2, 132.1, 132.3, 132.5, 135.0, 135.3, 140.3, 
143.6, 144.6; The enantiomers were analyzed by HPLC using an AD-H column at 254 
nm (2-propanol: hexane = 5: 95), 1.0 mL/min; Major enantiomer: tR = 13.5 min, 







 = 457.1193, found = 457.1173. 
 
                      










A yellow oil; Isolated in 81% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.17 (t, J = 6.8 Hz, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.90-2.95 (m, 1H), 
3.88-3.92 (m, 2H), 6.78 (s, 1H), 7.17-7.40 (m, 12H), 8.00 (s, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 23.3, 23.4, 24.5, 24.8, 54.2, 124.1, 125.2, 126.5, 126.6, 126.8, 128.6, 128.7, 
129.3, 130.4, 132.2, 135.1, 135.7, 145.2, 151.8, 154.2; The enantiomers were 
analyzed by HPLC using an AD-H column at 254 nm (2-propanol: hexane = 5: 95), 
1.0 mL/min; Major enantiomer: tR = 17.1 min, minor enantiomer: tR = 20.3 min. 
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A yellow oil; Isolated in 77% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.14 (m, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.90-2.95 (m, 1H), 3.88-3.92 (m, 
2H), 6.75 (s, 1H), 6.90-6.93 (m, 2H), 7.15-7.17 (m, 2H), 7.30 (s, 2H), 7.39-7.41 (m, 
3H), 8.00 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 23.3, 23.4, 30.0, 34.1, 53.6, 115.5, 
115.8, 124.2, 124.9, 126.4, 126.7, 128.6, 128.7, 129.4, 130.4, 130.8, 131.6, 132.4, 
135.0, 145.0, 151.8, 154.3; The enantiomers were analyzed by HPLC using an AD-H 
column at 254 nm (2-propanol: hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 
































A yellow solid; Isolated in 91% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300MHz, CDCl3) δ 
1.12-1.14 (m, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.90-2.95 (m, 1H), 3.85 (m, 2H), 
6.74 (s, 1H), 7.08-7.10 (d, J = 8.5 Hz, 2H), 7.17 (s, 2H), 7.30-7.42 (m, 6H), 8.00 (s, 
1H); 
13
C NMR (75 MHz, CDCl3) δ 23.3, 23.4, 24.6, 24.8, 30.1, 34.1, 53.7, 122.9, 
124.2, 124.8, 126.4, 126.7, 128.5, 129.6, 130.5, 130.7, 131.9, 132.5, 134.9, 135.0, 
144.6, 151.8, 154.4; The enantiomers were analyzed by HPLC using an AD-H column 
at 254 nm (2-propanol: hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 17.8 min, 


















 = 621.1216, found = 621.1240. 
 
(S)-4-(3-Nitro-1-(2,4,6-triisopropylphenylsulfonyl)-1,2-dihydroquinolin-2-yl)benzonit












A yellow oil; Isolated in 92% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.11-1.17 (m, 12H), 1.26-1.28 (d, J = 6.9 Hz, 6H), 2.91 (m, 1H), 3.84 (m, 2H), 6.81 (s, 
1H), 7.17 (s, 2H), 7.17-7.45 (m, 7H), 7.55-7.58 (d, J = 8.2 Hz, 2H), 8.08 (s, 1H); 
13
C 
NMR (75 MHz, CDCl3) δ 23.3, 23.4, 24.6, 24.8, 30.2, 34.1, 53.8, 112.8, 118.0, 124.8, 
126.2, 126.9, 127.6, 130.0, 130.5, 130.7, 132.5, 132.7, 134.9, 141.1, 143.9, 151.8, 
154.6; The enantiomers were analyzed by HPLC using an IA -H column at 254 nm 
(2-propanol: hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 36.6 min, minor 







= 566.2084, found = 566.2085.  
 










A yellow oil; Isolated in 83% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.17 (t, J = 7.2 Hz, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.28 (s, 3H), 2.90 (m, 
2H), 3.90 (m, 2H), 6.74 (s, 1H), 7.05-7.06 (m, 4H), 7.17 (s, 2H), 7.17-7.41 (m, 5H), 
8.00 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ = 21.0, 23.3, 23.4, 24.6, 24.8, 30.0, 34.1, 
124.1, 125.2, 126.4, 126.5, 126.7, 129.2, 129.3, 130.3, 131.0, 132.2, 132.7, 135.1, 
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138.6, 145.3, 151.8, 154.1; The enantiomers were analyzed by HPLC using an AD-H 
column at 254 nm (2-propanol: hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 





















A yellow oil; Isolated in 75% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.17 (m, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.93 (m, 1H), 3.75 (s, 1H), 3.90 (m, 
2H), 6.72-6.77 (m, 3H), 7.07-7.08 (d, J = 3.1 Hz, 2H), 7.12 (s, 2H), 7.30-7..49 (m, 
3H), 8.00 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 23.3, 23.4, 24.6, 24.8, 29.6, 30.0, 
53.8, 55.1, 114.0, 124.1, 125.1, 126.4, 126.5, 127.8, 128.2, 129.1, 130.3, 130.9, 132.2, 
135.1, 145.4, 151.8, 154.1, 159.9; The enantiomers were analyzed by HPLC using an 
AD-H column at 254 nm (2-propanol: hexane = 3: 97), 0.5 mL/min; Major 







 = 571.2237, found = 571.2249.  

















A yellow oil; Isolated in 90% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.17 (m, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.90-2.95 (m, 1H), 3.88-3.92 (m, 
2H), 6.76 (s, 1H), 7.14-7.29 (m, 10H), 7.40-7.41 (d, J = 3.6 Hz, 2H), 8.03 (s, 1H); 
13
C 
NMR (75 MHz, CDCl3) δ 23.4, 23.4, 24.5, 24.8, 30.1, 34.1, 53.7, 124.2, 124.9, 125.0, 
126.6, 126.9, 127.1, 129.0, 129.7, 129.9, 130.6, 132.5, 134.6, 134.8, 137.7, 144.5, 
151.9, 154.4. The enantiomers were analyzed by HPLC using an IA-H column at 254 
nm (2-propanol: hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 14.1 min, 























A yellow solid; Isolated in 86% yield after flash column chromatographic 
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purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.15 (m, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.91-2.96 (m, 1H), 3.85 (m, 2H), 
6.74 (s, 1H), 7.11-7.13 (m, 2H), 7.19 (s, 2H), 7.33-7.42 (m, 3H), 7.48-7.51 (d, J = 7.2 
Hz, 1H), 8.03 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 23.3, 23.4, 24.5, 25.8, 53.6, 
122.7, 124.2, 125.1, 125.3, 126.6, 126.9, 129.8, 130.0, 130.2, 131.9, 132.5, 134.8, 
138.0, 144.5, 151.9, 154.5; The enantiomers were analyzed by HPLC using an IA-H 
column at 254 nm (2-propanol: hexane = 3 : 97), 0.5 mL/min; Major enantiomer: tR = 















 = 619.1237 and 














A yellow oil; Isolated in 83% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.17 (m, 12H), 1.27-1.29 (d, J = 6.9 Hz, 6H), 2.27 (s, 3H), 2.91-2.95 (m, 1H), 
3.88-3.90 (m, 2H), 6.75 (s, 1H), 6.98 (m, 2H), 7.07-7.11 (m, 2H), 7.18 (s, 2H), 7.30 
(m, 1H), 7.37-7.40 (m, 2H), 7.46 (m, 1H), 8.00 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 
21.3, 23.3, 23.4, 24.5, 24.9, 29.6, 30.0, 34.1, 54.2, 123.7, 124.1, 125.3, 126.6, 127.6, 
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128.5, 129.3, 129.5, 130.4, 130.9, 132.2, 135.1, 135.5, 138.4, 145.3, 151.8, 154.2; The 
enantiomers were analyzed by HPLC using an IA-H column at 254 nm (2-propanol: 
hexane = 3: 97), 1.0 mL/min; Major enantiomer: tR = 6.4 min, minor enantiomer: tR = 






 = 555.2288, 













A yellow oil; Isolated in 86% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
0.87-0.89 (d, J = 6.7 Hz, 3H), 1.03-1.05 (d, J = 6.6 Hz, 3H), 1.11-1.17 (m, 12H), 
1.24-1.26 (d, J = 6.9 Hz, 6H), 2.84-2.94 (m, 1H), 3.72-3.81 (m ,2H), 5.63-5.67 (dd, J 
= 10.0 Hz, 4.11 Hz, 1H), 7.12 (s, 2H), 7.30-7.35 (m, 1H), 7.40-7.48 (m, 2H), 
7.53-7.56 (m, 1H), 7.68 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.2, 23.1, 23.4, 24,6, 
25.0, 30.2, 34.1, 40.5, 50.6, 123.9, 125.6, 126.7, 127.3, 127.8, 130.2, 131.3, 131.8, 
134.6, 147.3, 151.6, 153.9; The enantiomers were analyzed by HPLC using two 
combined IC-H column at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major 







= 507.2408, found = 507.2428. 
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(S)-2-(Naphthalen-2-yl)-3-nitro-1-(2,4,6-triisopropylphenylsulfonyl)-1,2-dihydroquin










A yellow oil; Isolated in 75% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 8:1); 
1
H NMR (300 MHz, CDCl3) δ 1.12-1.18 (m, 
12H), 1.28-1.47 (d, J = 6.9 Hz, 6H), 2.91-2.96 (m, 1H), 3.92 (m, 2H), 6.97 (s, 1H), 
7.19 (s, 2H), 7.18-7.52 (m, 8H), 7.68-7.78 (m, 3H), 8.09 (s, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 23.4, 23.5, 24.7, 25.0, 30.2, 34.2, 54.4, 124.3, 124.7, 125.3, 126.0, 126.3, 
126.5, 126.7, 126.8, 127.6, 128.1, 128.9, 129.7, 130.5, 131.1, 132.3, 132.9, 133.0, 
133.3, 135.1, 145.1, 151.9, 154.3; The enantiomers were analyzed by HPLC using 
two combined IC-H column at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; 







 = 591.2288, found = 591.2310. 
 
(S)-6-Chloro-3-nitro-2-phenyl-1-(2,4,6-triisopropylphenylsulfonyl)-1,2-dihydroquinol












A yellow oil; Isolated in 78% yield after flash column chromatographic 
purification (hexane: ethyl acetate = 10: 1 to 5:1); 
1
H NMR (300 MHz, CDCl3) δ 
1.12-1.13 (m, 12H), 1.24-1.25 (m, 6H), 2.87-2.92 (m, 1H), 3.81-3.87 (m, 2H), 6.70 (s, 
1H), 7.11-7.15 (m, 2H), 7.22-7.26 (m, 3H), 7.31-7.33 (m, 2H), 7.42 (s, 1H), 7.88 (s, 
1H); 
13
C NMR (75 MHz, CDCl3) δ 23.3, 23.4, 24.5, 24.8, 30.1, 34.1, 124.2, 126.5, 
126.7, 127.6, 128.0, 128.76, 128.8, 128.9, 129.0, 129.6, 130.4, 131.8, 132.1, 133.5, 
135.3, 146.1, 151.9, 154.5; The enantiomers were analyzed by HPLC using two 
combined IC-H columns at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major 



































Chapter 3 Asymmetric Synthesis of 2-Aryl-2,3-dihydro-4-quinolones 
via Bifunctional Thiourea-mediated Intramolecular Cyclization 
 
3.1 Introduction 
As another important class of six-membered N-heterocycles, the quinolones can 
be considered as a family of compounds with broad-spectrum antibiotic properties.
158
 




They have shown potent cytotoxic and antitubulin effects. Strong cytotoxic 
effects with ED50 values were demonstrated by these compounds in the nanomolar or 
subnanomolar range in almost all tumor cell lines. Since individual stereoisomers of 
quinolones displayed different biological acitivities, it is highly desirable to develop 
enantioselective routes to access this class of important antibiotics.  
However, the methods of asymmetric synthesis of chiral 
2-aryl-2,3-dihydro-4-quinolones were very limited. Generally, the synthesis of these 
racemic compounds are carried out by acid or base catalyzed isomerization of 
2‟-aminochalcones via the aza Michael reaction in the alumina or silica gel supported 
conditions.
161-166
 So far to the best of our knowledge, only two examples have been 
reported in the literature to synthesize the chiral compounds, both making use of 
transition metal-mediated catalytic processes. Hayashi and coworker reported an 
asymmetric synthesis of 2-aryl-2,3-dihydro-4-quinolones via a rhodium-catalyzed 
1,4-addition of arylzinc reagent to 4-quinolones.
167
 These 1,4-adducts can be obtained 
 60 
with high enantioselectivity by using (R)-binap as a ligand, and high yields are 








[RhCl(C2H4)2]2 (7.5 mol% Rh)
(R)-binap (8.2 mol%)
Me3SiCl (3.0 equiv)
THF, 20 oC, 20h;










Scheme 3-1 Asymmetric synthesis of 3-1 via a rhodium-catalyzed 1,4-addition 
 
Recently, Hou et al. disclosed a kinetic resolution of 2,3-dihydro-2-substituted 
4-quinolones by a palladium-catalyzed asymmetric allylic alkylation, affording chiral 



































R5 = (R)-1, 1'-bi-2-naphthol
(Sphos, R)-L1: R4 = H
(Rphos, R)-L2: R4 =H
(S, Rphos, R)-L3: R4 = i-Pr
(S, Rphos, R)-L4: R4 = Ph
Scheme 3-2 Kinetic resolution of palladium-catalyzed asymmetric allylic alkylation 
 
Given the biological importance of 2-aryl-2,3-dihydro-4-quinolones, developing 
organocatalytic synthetic methods for the practical preparation of these valuable 
 61 
molecules is on demand. 
Recently, a great method was induced by Scheidt group in the asymmetric 
synthesis of flavanones and chromanones.
169
 Cinchona alkaloids derived bifunctional 
thiouea catalysts were used to efficiently catalyze the cyclization reaction. After 
decarboxylation reaction, the chiral flavanones and chromanones were obtained with 





























 later extended this work by introducing fluorine to the chiral 
center formed by Oxa-Michael Addition to get the fluorinated flavanone derivatives in 








1) Proline, EtOH, rt







Scheme 3-4 Asymmetric synthesis of fluorinated flavanone derivatives 
 
These flavanones could also be prepared by Asymmetric Cyclization of 














EtOH, 110 oC, 30 h
3-11 36 % yield  
Scheme 3-5 Asymmetric Cyclization of 2-Hydroxychalcones catalyzed by Chiral 
CSA 
 
Inspired by these excellent work and considered about the advantages of 
cyclization reaction and its great utility in the natural product synthesis,
173-174
 an 
attractive strategy was designed to stereoselective synthesis of 
2-aryl-2,3-dihydro-4-quinolones through an intramolecular conjugate addition of 
aniline to a properly activated alkene moiety by cinchona alkaloids derived 
bifunctional thiourea catalysts (Figure 3-1). The key issue here is how to affect the 
cyclization in an efficient and stereocontrolled manner.  
In the previous chapter, the asymmetric preparation of 
3-nitro-1,2-dihydroquinolines was reported by a bifunctional thiouea-promoted 
cascade aza-Michael-Henry-dehydration reaction,
175
 in which the nitrogen 
 63 
nucleophiles were activatived by installing a sulfonyl group. Thus, we envisioned that 
the sufonyl substituted aniline could be used as the nucleophilic component; in the 
presence of bifunctional tertiary amine thiourea catalysts, 
176-181
 the acidic proton of 
the sulfonamide can be readily removed, initiating the subsequent aza-Michael 
type
182-188
 intramolecular cyclization reaction.  
To better activate the electrophiles, an ester group could be installed at the 
α-position of the carbonyl function. Such an ester group is expected to facilitate 
hydrogen bonding interactions between the substrates and the thiourea catalysts, 
leading to a better stereochemical control. With the established protocols for its 
decarboxylative cleavage, the ester group can be readily removed at the end of the 
synthesis, without affecting the integrity of the newly created stereogenic center at the 
2-position of chiral quinolones.  
 
 





3.2 Result and Discussion 
3.2.1 Catalysts and Solvent Screening 
To prove the validity of our proposed synthetic strategy, alkylidene β-ketoester 
3-15a with a properly installed neighboring sulfonamide group was treated with 
























3-14a: R1 = R2 = CH2CH3;
3-14b: R1/R2 = CH2CH2CH2CH2
Ar = 3,5-CF3-Ph
 
Figure 3-2 Bifunctional tertiary amine thiourea catalysts employed in the study 
 
To our delight, the intramolecular cyclization occurred smoothly to yield product 
3-16a in quantitative yield and with 87% ee. The next step is the cleavage of the ester 
group. Upon further treatment with TsOH at the elevated temperature, the 
decarboxylation 
189-193
 took place readily, and 2-phenyl-2,3-dihydro-4-quinolone 






























Scheme 3-6 Synthesis of 2-Phenyl-2,3-dihydro-4-quinolone 3-17a via Conjugate 
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addition- Decarboxylation Sequence 
 
The enantiomeric purity of the final quinolone products is determined by the 
stereochemical outcome of the first intramolecular cyclization step, as the second 
decarboxylation step will not compromise the stereogenic integrity of the quinolone 
intermediates created. The absoluted configuration of final product 6a was determined 
by comparing the exact HPLC condition referring to the literature.
194
 
The catalytic effects of various bifunctional catalysts (Table 3-1) and different 
reaction conditions in the intramolecular conjugate addition step were investigated, 
aiming to improve the enantioselectivity of the process. L-Threonine-derived 3-13, 
and L-tryptophan-based bifunctional catalysts 3-14a 
195
 and 3-14b all could promote 
the reactions which have shown great reactivities and enantioselectivities in the 
Michael reaction with other donors and accepters. However, the results in this 
reaction were disappointing. Only quinidine-derived bifunctional thiourea catalyst 
3-12 could give the satisfied result. The desired products were obtained with low 
enantioselectivity (Table 3-1, entries 2-4). A solvent screening revealed that toluene 
was the best reaction medium for the reaction. Other polar solvent, such as EtOAc and 
CH3CN did not provide the better results (Table 3-1, entries 8 and 10), which 
indicate that polar reaction medium may disturb the hydrogen bonding interaction 
between the substrates and the catalysts. By lowering the reaction temperature to 0 
o
C, 
the desired quinolone 3-17a could be obtained in high yield and with 94% ee (entry 
12). The sulfonyl group on the nitrogen was crucial, employment of alkylidene 
β-ketoester with the free amino group resulted in formation of the product with only 
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78% ee, comparing to a 94% ee under otherwise same reaction conditions.  
 








a) cat. (10 mol %), solvent








entry cat. solvent t
b







1 3-12 Toluene 5 rt 99/95 87 
2 3-13 Toluene 72 rt 79/89 11 
3 3-14a Toluene 24 rt 99/95 57 
4 3-14b Toluene 12 rt 99/95 20 
5 3-12 MeOH 9 rt 99/95 35 
6 3-12 CH2Cl2 51 rt 99/95 79 
7 3-12 Hexane 72 rt <30 -- 
8 3-12 EtOAc 3 rt 99/95 42 
9 3-12 THF 51 rt 99/95 36 
10 3-12 CH3CN 5 rt 99/91 73 
11 3-12 Acetone 5 rt 99/95 42 
12 3-12 Toluene 28 0 92/91 94 
 
a
 The reactions were performed with 3-15a (0.05 mmol) and catalyst (0.005 mmol) in anhydrous 
toluene (0.2 mL) at the temperature specified. 
b
 Time for step a. 
c
 Isolated yields for both steps. 
d
 
The ee value was determined by HPLC analysis on a chiral stationary phase. 
e
 Not determined. 
 
3.2.2 Reaction Scope 
The reaction scope was next studied, various alkylidene β-ketoesters with 
different substituents were examined, and the results are summarized in Table 3-2. 
It was found that para- or meta- substituted aromatic rings, regardless their 
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electronic nature, were well-tolerated for the reaction. In all the examples examined, 
good yields and excellent enantioselectivities were obtained (entries 1-6). For the 
alkene bearing an ortho-methyl-phenyl substituent, the desired product could still be 
obtained in good yield and with excellent enantioselectivity, although much longer 
reaction was required (entry 7). 2-Naphthyl-substituted alkylidene could also be 
employed, and high ee was attainable (entry 8). When the alkyl substituent was used, 
the final 2-iPr-2,3-dihydro-4-quinolone was prepared with 78% ee (entry 9). 
 







a) 3-12 (10 mol %), toluene, 0 oC















1 Ph 3-17a 28 92/91 94 
2 4-ClPh 3-17b 24 98/88 91 
3 4-CH3-Ph 3-17c 24 98/87 89 
4 3-CH3-Ph 3-17d 28 95/70 92 
5
d
 2-CH3-Ph 3-17e 96 93/86 83 
6 4-BrPh 3-17f 24 96/76 87 
7 3-F-Ph 3-17g 42 95/90 83 
8 2-Naphthyl 3-17h 24 92/88 84 
9 4-CH3CH2Ph 3-17i 24 98/91 94 
10 (CH3)2CH 3-17j 48 97/85 78 
 
a 
The reactions were performed with 3-15 (0.05 mmol), 3-12 (0.005 mmol) and 4Å molecular 
sieves in anhydrous toluene (0.2 mL) at 0 
o
C for the first step; 0.05 mmol TsOH in toluene (0.2 
mL) was used for the second step. 
b
 Isolated yields for both steps. 
c
 The ee value was determined 
by HPLC analysis on a chiral stationary phase. 
d






3.2.3 Synthesis of 2-Aryl-2,3-dihydro-4-quinolones  
Chiral 2-aryl-2,3-dihydro-4-quinolones could be synthesized by deprotection of 
the sulfonamide group to get the free amino group.
196-197
 The reductive cleavage of 
the sulfonyl protection was demonstrated in Scheme 3-7. When 3-17a (94% ee) was 
treated with magnesium in methanol at the refluxing condition, the desulfonated 
2,3-dihydro-2-aryl-quinolin-4(1H)-one 3-18 with 93% ee was obtained. The integrity 
of the newly created stereogenic center at the 2-position of chiral quinolones was not 















Scheme 3-7 Cleavage of the N-Sulfonyl Group 
 
3.3 Conclusion 
In conclusion, a new approach for the asymmetric preparation of biologically 
important 2-aryl-2,3-dihydro-quinolin-4(1H)-ones was developed. By installing a 
sulfonyl group on the nitrogen of anilines and an ester function on the alkylidene 
β-ketoesters, the intramolecular cyclization reactions proceeded in a highly 
enantioselective manner in the presence of tertiary amine-thiourea organic catalysts, 
and the subsequent removal the ester group was realized via an acidic decarboxylative 
process without affecting the newly generated 2-stereogenic center of the quinolones. 
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The reported procedure represents a practical asymmetric route to 
2-substituted-2,3-dihydro-4-quinolones, and this method may find wide applications 
in the synthesis of other bioactive nitrogen-containing cyclic structures. 
 
3.4 Experimental Section 
3.4.1 General Information 





C NMR spectra were recorded on a Bruker ACF300 or DPX300 
(300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in 
parts per million (ppm), and the residual solvent peak was used as an internal 
reference: proton (chloroform  7.26), carbon (chloroform  77.0). Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz 
(Hz). Low resolution mass spectra were obtained on a Finnigan/MAT LCQ 
spectrometer in ESI mode. All high resolution mass spectra were obtained on a 
Finnigan/MAT 95XL-T spectrometer. For thin-layer chromatography (TLC), Merck 
pre-coated TLC plates (Merck 60 F254) were used, and compounds were visualized 
with a UV light at 254 nm. Flash chromatography separations were performed on 





3.4.2 Representative Procedures 































Methyl 2-(tosylamino)benzoate II 
To a solution of methyl 2-aminobenzoate I (1.51g, 10 mmol) in CH2Cl2 (15 mL) 
was added pyridine (0.97 mL, 12 mmol) dropwise over 2 min. The reaction was 
stirred for 25 min, and a solution of 4-methylbenzene-1-sulfonyl chloride (2.28g, 12 
mmol) in CH2Cl2 was added dropwise. After stirring overnight, the reaction was 
quenched with sat. aq.NH4Cl (30 mL). The layers were separated and the aqueous 
layer extracted with CH2Cl2 several times. The combined organic layers were washed 
with brine (30 mL), and dried over MgSO4. Evaporation of the solvent under reduced 
pressure and purified via column chromatography (EtOAc: Hexanes = 1: 8) to give 
2.20 g of pale yellow solid II (72% yield). 
1
H NMR (300 MHz, CDCl3) δ 2.38 (s, 3H), 
3.89 (s, 3H), 7.03-7.06 (m, 1H), 7.23-7.24 (m, 2H), 7.29 (m, 1H), 7.45-7.47 (m, 1H), 
7.70-7.77 (m, 2H), 7.92-7.94 (m, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.5, 52.4, 115.9, 
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 = 328.0713, found = 328,0722. 
 
tert-Butyl 3-oxo-3-(2-(tosylamino)phenyl)propanoate III 
To a N2 purged 100 mL round bottom flask was added 20 mL of dry THF and 
diisopropylamine (5 mL, 36 mmol). The solution was cooled to -78 °C and n-BuLi 
(15 mL, 2.5 M) was added and the solution is warmed to 0 °C for 45 min. The 
solution is cooled to -78 °C and t-butyl acetate (3 mL, 24 mmol) in 20 mL THF was 
added dropwise over 10 minutes. After 90 min., methyl 2-(tosylamino)benzoate II 
(1.83 g, 6 mmol) in 15 mL of THF was added. The solution was allowed to warm to 
RT overnight and quenched with aq. NH4Cl (sat.), extracted with EtOAc (2 x 25 mL), 
washed brine (40 mL), dried Na2SO4, filtered, concentrated in vacuo. Purified via 
column chromatography (EtOAc: Hexanes = 1: 8) to give pale yellow solid III (1.45 g, 
62% yield). 
1
H NMR (300 MHz, CDCl3) δ 1.43 (s, 9H), 2.37 (s, 3H), 3.86 (s, 2H), 
7.08-7.10 (t, J = 1.1 Hz, 1H), 7.23-7.26 (d, J = 8.1 Hz, 2H), 7.48 (t, J = 1.3 Hz, 3H), 
7.70-7.78 (m, 4H), 11.29 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.4, 27.8, 48.3, 76.5, 
76.9, 77.4, 82.4, 118.7, 121.2, 122.4, 127.2, 130.0, 131.5, 135.2, 136.5, 140.5, 143.9, 




 = 412.13, 
found = 412.38. 
 
(Z)-tert-butyl 2-(2-(4-methylphenylsulfonamido)benzoyl)-3-phenylacrylate 3-15a 
To a solution of 5 mL toluene in 25 mL round bottom flask was added 
benzaldehyde (41 μL, 0.4 mmol), tert-butyl 
 72 
3-oxo-3-(2-(tosylamino)phenyl)propanoate III (156mg, 0.4 mmol) with piperidine (2 
μL, 0.02 mmol) and glacial acetic acid (1μL, 16.5 mmol) as well as 4Å molecular 
sieve (30 mg, 0.1 mmol). The heterogenous mixture was stirred at RT for 5 h. The 
reaction was taken up in EtOAc (10 mL) and washed with brine (25 mL). The organic 
layer was dried with Na2SO4. After concentration, the residue was purified by flash 
column (EtOAc: Hexanes = 1: 8) to afford 3-15a as a white solid (227 mg, 68% yield). 
1
H NMR (300 MHz, CDCl3) δ 1.34 (s, 9H), 2.43 (s, 3H), 6.94-7.00 (m, 1H), 7.22-7.34 
(m, 7H), 7.45-7.50 (m, 1H), 7.68-7.91 (m, 5H), 11.51 (s, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 21.5, 27.7, 82.4, 117.6, 121.3, 122.2, 127.3, 128.8, 129.7, 129.9, 130.3, 







 = 500.1502, found = 500.1520. 
 




















3-15a 3-16a  
 
(Z)-Tert-buty-2-(2-(4-methylphenylsulfonamido)benzoyl)-3-phenylacrylate 
3-15a (23.4 mg, 0.05 mmol), thiourea 3-12 (2.97 mg, 0.005 mmol) and 4Å molecular 
sieve (20 mg) in toluene (200 L) was stirred in toluene (200 μL) at 0 oC for 28 h. 
 73 
The mixture was then diluted with water, and extracted with CH2Cl2 several times. 
The combined organic layers were dried over anhydrous Na2SO4. After concentration, 
the residue was purified by flash chromatographic column (EtOAc: Hexanes = 1: 10) 
to afford 3-16a as a light yellow solid (21.06 mg, 92% yield). 
1
H NMR (300 MHz, 
CDCl3) δ 1.51 (s, 9H), 2.39 (s, 3H), 6.33 (s, 1H), 7.13-7.44 (m, 11H), 7.65-7.71 (m, 
2H), 12.04 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.4, 28.1, 55.7, 82.4, 124.1, 125.1, 
126.7, 126.8, 127.0, 127.6, 128.0, 128.1, 129.2, 131.5, 135.5, 135.9, 138.8, 143.8, 






 = 500.1502, 
found = 500.1520. 
 

















p-Toluenesulfonic acid (8.6 mg, 0.05 mmol) was added to the solution of  
tert-butyl 4-hydroxy-2-phenyl-1-tosyl-1,2-dihydroquinoline-3-carboxylate 3-16a 
(23.4 mg, 0.05 mmol) in toluene and the solution was heated to 80 °C, and the 
reaction was completed in 5h. The solution was allowed to cool down, diluted with 
EtOAc (5 mL) and then washed with brine. The combined organic layers were dried 
over anhydrous Na2SO4. After concentration, the residue was purified by flash 
chromatographic column (EtOAc: Hexanes = 1: 10) to afford 3-17a as a light yellow 
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solid (19.60 mg, 91 % yield). 
1
H NMR (300 MHz, CDCl3) δ 2.43 (s, 3H), 2.63-2.67 
(m, 1H), 3.01-3.05 (m, 1H), 5.96 (m, 1H), 7.19-7.32 (m, 8H), 7.54-7.62 (m, 3H), 
7.86-7.92 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 21.6, 39.5, 57.8, 125.7, 126.0, 126.2, 
126.9, 127.0, 127.1, 127.9, 128.6, 130.2, 135.0, 136.7, 137.7, 140.2, 144.7, 192.0. 






 = 400.1168, found = 
400.1185. 
 
















To a mixture of 3-17a (23.4 mg, 0.05 mmol) and activated Mg (12 mg, 0.05 
mmol) in a 25 mL round bottom flask was added anhydrous methanol (5 mL). The 
reaction solution was brought to reflux overnight. After cooling down to room 
temperature, the reaction mixture was quenched by adding 1 M aqueous HCl, and 
extracted by CH2Cl2 several times. The combined organic layers were dried over 
anhydrous Na2SO4. After concentration, the residue was purified by flash 
chromatographic column (EtOAc: hexanes = 1: 8) to afford 3-18 as a yellow solid 
(7.47 mg, 67 % yield). 
 
3.4.3 Determination of the Absolute Configurations of Products   
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The NMR spectra of 3-18 were consistent with the literature data.
1 
The 
enantiomers of 3-18 were analyzed by chiral phase HPLC using IC-H column at 214 
nm (2-propanol/hexane = 20/80), flow rate = 0.7 mL/min; major enantiomer: tR = 14.6 
min, minor enantiomer: tR = 15.9 min (literature
1
: major enantiomer: tR = 14.9 min, 
















A white solid; Isolated in 60% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.35 (s, 9H), 
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2.45 (s, 3H), 6.95-7.01 (m, 1H), 7.18 (s, 4H), 7.30-7.32 (m, 2H), 7.46-7.47 (m, 1H), 
7.49-7.52 (m, 1H), 7.64-7.67 (m, 1H), 7.76-7.90 (m, 3H), 11.44 (s, 1H); 
13
C NMR (75 
MHz, CDCl3) δ 21.5, 27.7, 82.7, 117.8, 121.2, 122.3, 127.3, 129.1, 129.7, 131.0, 









 = 534.1112, found = 534.1122. 
 







A white solid; Isolated in 68% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.33 (s, 9H), 
2.33 (s, 3H), 2.43 (s, 3H), 6.94-6.99 (m, 3H), 7.03-7.05 (d, J = 8.0 Hz, 2H), 7.15-7.18 
(d, J = 8.2 Hz, 2H), 7.29-7.32 (m, 1H), 7.68-7.69 (d, J = 1.5 Hz, 1H), 7.71-7.81 (m, 
2H), 7.89-7.91 (m, 2H), 11.53 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.4, 21.5, 27.7, 
82.2, 117.6, 121.4, 122.2, 127.3, 129.6, 129.7, 129.8, 130.1, 131.1, 133.1, 135.4, 
























A white solid; Isolated in 66% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.34 (s, 9H), 
2.27 (s, 3H), 2.42 (s, 3H), 6.94-6.99 (m, 1H), 7.04-7.14 (m, 4H), 7.28-7.30 (m, 2H), 
7.46-7.48 (t, J = 1.3 Hz, 3H), 7.67-7.68 (d, J = 1.5 Hz, 2H), 7.70-7.80 (m, 2H), 
7.88-7.91 (d, J = 8.4 Hz, 2H), 11.52 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.2, 21.4, 
27.7, 82.3, 117.5, 121.4, 122.2, 126.7, 127.3, 128.6, 129.7, 131.0, 131.2, 132.0, 132.5, 







 = 514.1659, found = 514.1678. 
 








A white solid; Isolated in 59% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.34 (s, 9H), 
2.41 (s, 3H), 2.45 (s, 3H), 6.93-7.06 (m, 3H), 7.19-7.30 (m, 5H), 7.41-7.47 (m, 1H), 
7.66-7.74 (m, 2H), 7.82-7.85 (m, 2H), 8.09 (s, 1H), 11.42 (s, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 19.9, 21.4, 27.7, 82.4, 117.6, 121.6, 122.0, 126.0, 127.2, 128.3, 129.5, 129.7, 
129.9, 130.5, 132.0, 133.5, 135.2, 136.7, 137.76, 140.50, 140.96, 143.84, 198.9.. 



















A light yellow solid; Isolated in 48% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.33 (s, 9H), 
2.43 (s, 3H), 6.95-6.97 (m, 1H), 7.08-7.10 (d, J = 5.1 Hz, 2H), 7.29-7.32 (m, 4H), 
7.48 (m, 1H), 7.63-7.65 (m, 1H), 7.72 (s, 1H), 7.80-7.82 (d, J = 5.3 Hz, 1H), 
7.86-7.88 (m, 2H), 11.43 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.60, 27.76, 82.79, 
117.9, 121.3, 122.5, 124.9, 127.3, 129.8, 131.3, 131.6, 132.1, 133.0, 133.1, 135.8, 

































A yellow oil; Isolated in 36% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.34 (s, 9H), 
2.41 (s, 3H), 6.95-7.08 (m, 4H), 7.19-7.31 (m, 3H), 7.45-7.47 (m, 1H), 7.65-7.68 (m, 
1H), 7.74-7.77 (d, J = 8.0 Hz, 2H), 7.87-7.90 (d, J = 8.2 Hz, 2H), 11.44 (s, 1H); 
13
C 
NMR (75 MHz, CDCl3) δ 21.4, 27.6, 82.8, 116.1, 116.4, 117.1, 11.4, 117.6, 121.1, 
122.2, 125.6, 127.2, 129.7, 130.4, 130.5, 132.9, 133.7, 135.7, 136.6, 140.1, 140.2, 

















A white solid; Isolated in 62% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.37 (s, 9H), 
2.45 (s, 3H), 6.95 (m, 1H), 7.25-7.28 (m, 3H), 7.30-7.54 (m, 3H), 7.61-7.64 (d, J = 




NMR (75 MHz, CDCl3) δ 21.5, 27.7, 82.4, 11.6, 121.4, 122.3, 125.5, 126.7, 127.3, 
127.5, 127.7, 128.6, 128.7, 129.7, 130.1, 131.7, 132.2, 133.0, 135.5, 136.8, 140.7, 
















A white solid; Isolated in 68% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.21 (m, 3H), 
1.33 (s, 9H), 2.42 (s, 3H), 2.61-2.63 (m, 2H), 6.96-6.99 (t, J = 0.8 Hz, 1H), 7.05-7.08 
(d, J = 8.2 Hz, 2H), 7.18-7.21 (d, J = 8.2 Hz, 2H), 7.28-7.30 (m, 2H), 7.47-7.48 (m, 
1H), 7.69 (d, 1H), 7.78-7.80 (m, 2H), 7.88-7.91 (m, 2H), 11.56 (s, 1H); 
13
C NMR (75 
MHz, CDCl3) δ 15.0, 21.5, 27.7, 28.6, 82.2, 117.6, 121.4, 122.3, 127.3, 128.4, 128.5, 
129.7, 130.0, 130.2, 131.1, 133.1, 135.4, 136.8, 140.6, 141.8, 143.9, 147.1, 163.5, 





















A white solid; Isolated in 56% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 0.95-0.97 (d, J = 
6.6 Hz, 6H), 1.27 (s, 9H), 2.04-2.27 (m, 1H), 2.37 (s, 3H), 6.78-6.81 (m, 1H), 
7.01-7.07 (m, 1H), 7.22-7.24 (d, J = 8.0 Hz, 2H), 7.46-7.51 (m, 1H), 7.59-7.62 (m, 
1H), 7.76-7.80 (m, 3H), 11.34 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.4, 21.6, 27.6, 
29.0, 81.9, 118.4, 122.1, 122.3, 127.1, 129.6, 132.6, 133.3, 135.2, 136.7, 140.3, 143.8, 







466.1659, found = 466.1675. 
 








A light yellow solid; Isolated in 92 % yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.51 (s, 9H), 
2.39 (s, 3H), 6.33 (s, 1H), 7.13-7.44 (m, 11H), 7.65-7.71 (m, 2H), 12.04 (s, 1H); 
13
C 
NMR (75 MHz, CDCl3) δ 21.4, 28.1, 55.7, 82.4, 124.1, 125.1, 126.7, 126.8, 127.0, 
127.6, 128.0, 128.1, 129.2, 131.5, 135.5, 135.9, 138.8, 143.8, 162.3, 169.8.The 
enantiomers were analyzed by HPLC using an AD-H column at 254 nm (2-propanol: 
hexane = 5: 95), 1.0 mL/min; Major enantiomer: tR = 7.6 min, minor enantiomer: tR = 
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 = 500.1502, 










A light yellow solid; Isolated in 98% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.50 (s, 9H), 
2.39 (s, 3H), 6.27 (s, 1H), 7.12-7.15 (m, 2H), 7.19-7.34 (m, 7H), 7.41-7.45 (m, 1H), 
7.65-7.69 (m, 2H), 12.03 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.4, 28.1, 55.2, 82.6, 
97.5, 124.1, 124.9, 126.8, 128.1, 128.3, 128.4, 129.2, 131.6, 133.5, 135.2, 135.6, 
137.4, 144.0, 162.5, 169.6. The enantiomers were analyzed by HPLC using an IA-H 
column at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major enantiomer: tR = 









 = 534.1112, found = 534.1122. 
 







A white solid; Isolated in 98% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.51 (s, 9H), 
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2.28 (s, 3H), 2.39 (s, 3H), 6.29 (s, 1H), 7.02-7.43 (m, 11H), 7.64-7.70 (m, 2H), 12.03 
(s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 20.9, 21.4, 28.1, 55.5, 82.3, 98.1, 124.1, 125.1, 
126.6, 126.8, 126.9, 128.1, 128.8, 129.2, 131.4, 135.5, 135.8, 135.9, 137.2, 143.8, 
162.2, 169.9. The enantiomers were analyzed by HPLC using an AD-H column at 254 
nm (2-propanol: hexane = 5 : 95), 1.0 mL/min; Major enantiomer: tR = 7.9 min, minor 







 = 514.1659, found = 514.1678. 
 







A white solid; Isolated in 95% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.52 (s, 9H), 
2.30 (s, 3H), 2.39 (s, 3H), 6.29 (s, 1H), 7.00-7.16 (m, 6H), 7.26-7.35 (m, 3H), 
7.41-7.46 (m, 1H), 7.65-7.72 (m, 2H), 12.04 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 
21.3, 21.4, 28.1, 55.6, 82.4, 98.1, 123.9, 124.1, 125.1, 126.6, 126.8, 127.8, 127.9, 
128.2, 128.4, 129.2, 131.4, 135.5, 135.9, 137.7, 138.7, 143.8, 162.3, 169.8.The 
enantiomers were analyzed by HPLC using an AS-H column at 254 nm (2-propanol: 
hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 27.3 min, minor enantiomer: tR 






 = 514.1659, 
found = 514.1678. 
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A white solid; Isolated in 93% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.48 (s, 9H), 
2.39 (s, 3H), 2.80 (s, 3H), 6.57 (s, 1H), 6.65-6.67 (m, 1H), 6.83-6.86 (m, 1H), 
7.09-7.14 (m, 3H), 7.20-7.34 (m, 3H), 7.36-7.43 (m, 2H), 7.51-7.54 (m, 2H), 
7.67-7.70 (m, 1H), 11.9 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 19.9, 21.4, 53.5, 82.3, 
123.8, 125.3, 126.5, 127.0, 127.2, 127.3, 127.9, 128.9, 129.1, 130.9, 131.3, 134.4, 
135.1, 135.8, 137.5, 143.8, 162.4, 169.5. The enantiomers were analyzed by HPLC 
using an IA-H column at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major 



















A light yellow solid; Isolated in 96% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.51 (s, 9H), 
2.40 (s, 3H), 6.25 (s, 1H), 7.12-7.20 (m, 4H), 7.30-7.45 (m, 6H), 7.64-7.69 (m, 2H), 
12.03 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 21.4, 28.1, 55.23, 82.6, 97.4, 121.7, 
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124.2, 124.9, 126.8, 126.9, 128.1, 128.8, 129.2, 130.9, 131.3, 131.6, 132.4, 135.2, 
135.6, 138.0, 144.0, 162.5. The enantiomers were analyzed by HPLC using an AD-H 
column at 254 nm (2-propanol: hexane = 3 : 97), 0.5 mL/min; Major enantiomer: tR = 




























A light yellow solid; Isolated in 95% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.52 (s, 1H), 
2.39 (s, 3H), 6.30 (s, 3H), 6.90-7.00 (m, 1H), 7.03-7.10 (m, 1H), 7.13-7.22 (m, 4H), 
7.28-7.35 (m, 3H), 7.43-7.46 (m, 1H), 7.65-7.72 (m, 2H), 12.04 (s, 1H); 
13
C NMR (75 
MHz, CDCl3) δ 21.4, 28.1, 55.3, 82.6, 97.5, 113.9, 114.2, 114.4, 114.7, 122.6, 124.2, 
124.9, 126.8, 128.1, 129.2, 129.5, 129.6, 131.6, 135.2, 135.7, 141.6, 141.7, 144.0, 
162.5, 164.3. The enantiomers were analyzed by HPLC using an AS-H column at 254 
nm (2-propanol: hexane = 3: 97), 0.2 mL/min; Major enantiomer: tR = 60.6 min, 

















A white solid; Isolated in 92% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.50 (s, 9H), 
2.41 (m, 3H), 6.49 (s, 1H), 7.15-.18 (d, J = 8.1 Hz, 2H), 7.27-7.28 (d, J = 1.1 Hz, 2H), 
7.30-7.46 (m, 5H), 7.57 (s, 1H), 7.63-7.80 (m, 6H), 12.15 (s, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 21.5, 28.1, 55.9, 82.5, 97.7, 124.1, 125.1, 125.6, 125.7, 125.9, 126.7, 126.9, 
127.4, 128.0, 128.2, 129.2, 131.5, 132.9, 135.4, 135.8, 136.2, 143.9, 162.6, 169.9. The 
enantiomers were analyzed by HPLC using an AD-H column at 254 nm (2-propanol: 
hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 43.9 min, minor enantiomer: tR 






 = 550.1659, 










A light yellow solid; Isolated in 98% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 1.20 (m, 3H), 
1.52 (s, 9H), 2.39 (s, 3H), 2.58-2.60 (m, 4H), 6.30 (s, 1H), 7.04-7.07 (d, J = 8.2 Hz, 
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2H), 7.12-.7.15 (d, J = 8.1 Hz, 2H), 7.20-7.22 (d, J = 8.1 Hz, 2H), 7.28-7.36 (m, 3H), 
7.41-7.43 (m, 1H), 7.65-7.72 (m, 2H), 12.03 (br s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 
15.1, 21.4, 28.1, 28.3, 55.5, 76.5, 77.0, 77.4, 82.3, 98.2, 124.1, 125.1, 126.6, 126.8, 
126.9, 127.5, 128.1, 129.2, 131.4, 135.5, 136.0, 136.1, 143.4, 143.8, 162.2, 169.8. The 
enantiomers were analyzed by HPLC using an AD-H column at 254 nm (2-propanol: 
hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 21.0 min, minor enantiomer: tR 






 = 528.1815, 
found = 528.1830. 
 






A light yellow solid; Isolated in 97% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 0.88-1.02 (m, 
6H), 1.60 (s, 9H), 2.35 (s, 3H), 4.75-4.78 (d, J = 9.4 Hz, 1H), 7.06-7.08 (d, J = 8.1 Hz, 
1H), 7.24-7.52 (m ,3H), 7.64-7.67 (m, 1H), 7.79 (d, J = 0.8 Hz, 1H), 7.81-7.82 (d, J = 
0.84 Hz, 1H), 11.94 (br s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 19.0, 19.4, 21.4, 28.2, 
32.6, 59.0, 82.0, 98.7, 124.2, 125.2, 126.4, 126.6, 127.8, 129.0, 131.2, 135.8, 136.2, 
143.4, 161.2. The enantiomers were analyzed by HPLC using an IA-H column at 254 
nm (2-propanol: hexane = 2: 98), 0.5 mL/min; Major enantiomer: tR = 18.7 min, 















A light yellow solid; Isolated in 91% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 5); 
1
H NMR (300 MHz, CDCl3) δ 2.43 (s, 3H), 
2.63-2.67 (m, 1H), 3.01-3.05 (m, 1H), 5.96 (m, 1H), 7.19-7.32 (m, 8H), 7.54-7.62 (m, 
3H), 7.86-7.92 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 21.6, 39.5, 57.8, 125.7, 126.0, 
126.2, 126.9, 127.0, 127.1, 127.9, 128.6, 130.2, 135.0, 136.7, 137.7, 140.2, 144.7, 
192.0. The enantiomers were analyzed by HPLC using an IA-H column at 254 nm 
(2-propanol: hexane = 5: 95), 1.0 mL/min; Major enantiomer: tR = 24.6 min, minor 













A light yellow solid; Isolated in 88% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.42 (s, 3H), 
2.61-2.65 (dd, J = 18.0 MHz, 1H), 2.96-3.00 (dd, J = 18.0 MHz, 1H), 5.91-5.92 (d, J 
= 5.7 MHz, 1H), 7.21-7.29 (m, 8H), 7.56-7.61 (m, 3H), 7.87-7.92 (m, 2H); 
13
C NMR 
(125 MHz, CDCl3) δ 21.6, 39.4, 57.3, 125.8, 125.9, 126.1, 127.0, 127.2, 128.3, 128.8, 
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130.2, 133.9, 135.2, 136.3, 136.5, 139.9, 144.8, 191.7. The enantiomers were 
analyzed by HPLC using an IA-H column at 254 nm (2-propanol: hexane = 3: 97), 1 
mL/min; Major enantiomer: tR = 37.0 min, minor enantiomer: tR = 40.0 min. HRMS 






 = 410.0623, found = 410.0609. [α]25D 







A light yellow solid; Isolated in 87% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.23 (s, 3H), 
2.40 (s, 3H), 2.58-2.62 (dd, J = 17.7 MHz, 1H), 2.96-3.00 (dd, J = 18.0 MHz, 1H), 
5.89-5.90 (d, J = 5.7 MHz, 1H), 7.01-7.03 (m, 2H), (m, 2H), 7.16-7.19 (m, 3H), 
7.23-7.26 (m, 2H), 7.51-7.53 (m, 1H), 7.57-7.59 (m, 2H), 7.84-7.88 (m, 2H); 
13
C 
NMR (125 MHz, CDCl3) δ 20.9, 21.6, 39.5, 57.6, 125.7, 126.0, 126.2, 126.8, 127.0, 
127.1, 129.3, 130.1, 134.7, 134.9, 136.7, 137.6, 140.1, 144.6, 192.2. The enantiomers 
were analyzed by HPLC using an IA-H column at 254 nm (2-propanol: hexane = 3: 
97), 1 mL/min; Major enantiomer: tR = 34.7 min, minor enantiomer: tR = 37.8 min. 






 = 390.1169, found = 390.1173. 










A white solid; Isolated in 70% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.24 (s, 3H), 
2.40 (s, 3H), 2.57-2.62 (dd, J = 18.0 MHz, 1H), 2.97-3.00 (d, J = 17.0 MHz, 1H), 
5.88-5.89 (d, J = 5.6 MHz, 1H), 6.97-7.10 (m, 2H), 7.17-7.26 (m, 3H), 7.50-7.59 (m, 
6H), 7.84-7.90 (m, 2H); 
13
C NMR (125 MHz, CDCl3) δ 21.4, 21.6, 39.5, 57.7, 123.9, 
125.7, 126.0, 126.2, 127.0, 127.1, 127.8, 128.4, 128.6, 130.1, 135.0, 136.7, 137.7, 
138.3, 140.2, 144.6, 192.1. The enantiomers were analyzed by HPLC using an IA-H 
column at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major enantiomer: tR = 
















A light yellow solid; Isolated in 86% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.40 (s, 3H), 
2.65 (s, 3H), 2.87 (s, 2H), 6.13-6.15 (m, 1H), 6.75-6.76 (d, J = 8.2 MHz, 1H), 6.91 (m, 
1H), 7.11-7.21 (m, 3H), 7.26-7.29 (m, 2H), 7.44-7.46 (d, J = 8.2 MHz, 1H), 7.54-7.56 




(125 MHz, CDCl3) δ 20.2, 21.6, 40.2, 56.3, 125.8, 126.4, 126.6, 126.9, 127.0, 127.3, 
127.4, 128.2, 129.9, 131.5, 135.0, 136.0, 136.1, 137.3, 140.5, 144.6, 192.7. The 
enantiomers were analyzed by HPLC using an IA-H column at 254 nm (2-propanol: 
hexane = 3: 97), 1.0 mL/min; Major enantiomer: tR = 26.5 min, minor enantiomer: tR 






 = 390.1169, found = 







A light yellow solid; Isolated in 76% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.40 (s, 3H), 
2.58-2.63 (dd, J = 18.0 MHz, 1H), 2.93-2.97 (dd, J = 18.0 MHz, 1H), 5.86-5.87 (d, J 
= 6.2 MHz, 1H), 7.16-7.19 (m, 3H), 7.20-7.26 (m, 2H), 7.34-7.36 (d, J = 8.2 MHz, 
2H), 7.54-7.58 (m, 3H), 7.84-7.89 (m, 2H); 
13
C NMR (125 MHz, CDCl3) δ 21.6, 39.3, 
57.3, 122.1, 125.8, 125.9, 126.1, 127.0, 127.2, 128.7, 130.2, 131.8, 135.2, 136.5, 
136.8, 139.9, 144.8, 191.6. The enantiomers were analyzed by HPLC using an IA-H 
column at 254 nm (2-propanol: hexane = 3: 97), 0.5 mL/min; Major enantiomer: tR = 
























A light yellow solid; Isolated in 90% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.41 (s, 3H), 
2.59-2.63 (dd, J = 18.0 MHz, 1H), 2.94-2.98 (dd, J = 17.7 MHz, 1H), 5.90-5.91 (d, J 
= 5.7 MHz, 1H), 6.87-6.88 (m, 1H), 7.02-7.05 (m, 2H), 7.19-7.25 (m, 3H), 7.55-7.59 
(m, 3H), 7.84-7.92 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 21.5, 39.3, 57.3, 114.1, 
114.4, 114.8, 115.1, 122.4, 125.9, 126.1, 126.9, 127.1, 130.1, 130.2, 135.2, 136.3, 
139.9, 144.8, 191.5. The enantiomers were analyzed by HPLC using an IA-H column 
at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major enantiomer: tR = 36.1 min, 














A white solid; Isolated in 88% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 2.46 (s, 3H), 
2.67-2.75 (dd, J = 18.0 MHz, 1H), 3.16-3.22 (d, J = 18.0 MHz, 1H), 6.10-6.12 (d, J = 
5.9 MHz, 1H), 7.17-7.20 (t, J = 7.2 MHz, 1H), 7.21-7.22 (s, 3H), 7.29-7.72 (m, 7H), 
7.74-7.95 (m, 5H); 
13
C NMR (75 MHz, CDCl3) δ 21.5, 39.1, 57.8, 125.2, 125.7, 125.8, 
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125.9, 126.2, 126.3, 126.9, 127.0, 127.4, 128.0, 128.6, 130.1, 132.6, 132.7, 135.1, 
136.6, 139.9, 144.7, 192.1. The enantiomers were analyzed by HPLC using an IA-H 
column at 254 nm (2-propanol: hexane = 3: 97), 1.0 mL/min; Major enantiomer: tR = 














A light yellow solid; Isolated in 91% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (500 MHz, CDCl3) δ 1.17 (m, 3H), 
2.42 (s, 3H), 2.55-2.66 (m, 3H), 2.99-3.03 (m, 1H), 5.92-5.93 (d, J = 5.6 MHz, 1H), 
7.06-7.08 (d, J = 8.9 MHz, 1H), 7.19-7.22 (m, 3H), 7.26-7.29 (m, 2H), 7.52-7.56 (m, 
1H), 7.60-7.62 (m, 2H), 7.87-7.92 (m, 2H); 
13
C NMR (125 MHz, CDCl3) δ 15.2, 21.6, 
28.3, 39.6, 57.6, 125.6, 125.9, 126.1, 126.9, 127.0, 128.1, 130.1, 134.9, 135.0, 136.7, 
140.2, 143.8, 144.6, 192.2. The enantiomers were analyzed by HPLC using an IA-H 
column at 254 nm (2-propanol: hexane = 3: 97), 1 mL/min; Major enantiomer: tR = 
















A light yellow solid; Isolated in 85% yield after flash column chromatographic 
purification (EtOAc: Hexanes = 1: 8); 
1
H NMR (300 MHz, CDCl3) δ 0.97-1.03 (m, 
6H), 1.29 (m, 2H), 1.56-1.66 (m, 3H), 4,89-4.92 (d, J = 9.1 MHz, 1H), 7.09-7.11 (d, J 
= 8.1 MHz, 1H), 7.31-7.38 (m, 3H), 7.59 (m, 1H), 7.74-7.86 (m, 2H); 
13
C NMR (75 
MHz, CDCl3) δ 18.8, 19.2, 21.4, 29.6, 32.5, 50.8, 96.5, 124.5, 124.8, 126.6, 126.7, 
127.8, 129.1, 132.4, 135.5, 136.9, 143.8, 164.3, 174.6. The enantiomers were 
analyzed by HPLC using an IA-H column at 254 nm (2-propanol: hexane = 10: 90), 1 
mL/min; Major enantiomer: tR = 9.3 min, minor enantiomer: tR = 8.4 min. HRMS (EI) 






























Sulfur-containing cyclic organic compounds, with their unique chemical 
properties and potential synthetic applications,
198-201
 as well as interesting biological 
and physiological activities,
202-204
 have attracted much attention in recent years. These 
sulfur-containing cyclic organic molecules can be classified on the basis of the 
functional groups and chemical reactions involved with DNA.
205
 The antitumor 
antibiotic leinamycin can be considered as a structural type of DNA-damaging agent. 
(Figure 4-1)  
This natural product was isolated by researchers at Kyowa Hakko Kogyo Ltd. 
from a strain of Streptomyces found in soil samples collected near Miyagi, Japan.
206
 
The structure was analyzed by NMR and IR spectroscopy and X-ray crystallography 
and also confirmed by total synthesis.
207
 Interestingly, in vitro experiments revealed 
that leinamycin was a thiol-dependent DNA cleavage agent.
208
 The strand cleavage 
was caused by involving the conversion of molecular oxygen to DNA-cleaving 
oxygen radicals as shown in the Scheme 4-1.
209
 By inspection of its structure, it was 
suggested that 1,2-dithiolan-3-one 1-oxide heterocycle was the most reactive portion 





















Figure 4-1 Selective examples shown DNA-cleaving acvtivities 
 
O2 O2
.- H2O2 + M




Scheme 4-1 Propose mechanism of DNA cleavage 
 
Based on these discoveries, numbers of leinamycin derivatives with 
1,2-dithiolan-3-one 1-oxide heterocycle cores were synthesized and a model substrate 
3H-1,2-benzodithiol-3-one 1,1-dioxide was applied to investigate the DNA-cleavage 
reaction. This molecule was later known as Beaucage‟s sulfurizing agent, in which 
micromolar concentration could efficiently lead to thiol-dependent DNA cleavage.
210
  
Besides disulfide-derived functionalities, the trithiol functional groups have also 
be proven to be sufficient in causing DNA cleavage reaction. Varacin C, as a family 
member of varacin, which possesses an unique benzotrithiol 1-oxide functionality, has 
been found to exhibit potent antifungal activity against Candida albicans and possess 
potent antitumor activity against human colon tumor cell line HCT 116.
211-214
 It was 
discovered in the Far Eastern ascidian Polycitor sp. by Makarieva and coworkers in 
1995.
215
 The total synthesis of varacin C was first reported in 2002,
216
 and it was 
demonstrated that this antibiotic displayed potent thiol-dependent DNA-cleaving 
activity 
217
 that far exceeded that of varacin. It was further demonstrated that an acidic 
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Figure 4-2 Structure of varacin and varacin C 
 
4.2 Project Objectives 
Although numbers of examples have shown that sulfur-containing cyclic organic 
compounds possess great biological activities especially in thiol dependent DNA 
cleavage reaction, the whole picture has not been described in details for this 
magnificent reaction and many points could be thought over further. For example, 
although 1,2-dithiolan-3-one 1-oxide heterocycle in leinamycin seemed to be proved 
to be crucial in thiol dependent DNA cleavage reaction, the effect of side chain in this 
core has not been investigated yet. It may play important role as well in the reaction. 
In addition, other family members of varacin C, like varacin B, which is quite similar 
structure, has not been applied in the DNA cleavage reaction. It may be a good 
sulfurizing agent as well. So all these provide us enough room to expand our 
understanding and go further inside to see more clearly of this reaction. 
In this project, new sulfur-containing organic molecules were synthesized and 
the DNA-cleaving abilities were evaluated as well. More details about the synthesis of 
the new designed sulfur-containing organic molecules and experimental results of 
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their thiol dependent DNA-cleaving reactions will be described in the following 
sections. 
 
4.3 Result and Disscusion 
4.3.1 Synthesis of Aminomethylated Beaucage’s Reagent 
Beaucage‟s reagent, which contains 3H-1,2-benzodithiol-3-one 1,1-dioxide, has 
been proved to be efficient sulfurizing agent in catalyzing the thiol dependent DNA 
cleavage reaction. The concentration of the Beaucage‟s reagent could be low into 
micromolar scale. However, besides 3H-1,2-benzodithiol-3-one 1,1-dioxide core, the 
other functionalities in the Beaucage‟s reagent have never been investigated and the 
effect of these side chains are unknown so far. Introduction of amino moiety in 
Beaucage‟s reagent is supposed to result in better DNA cleaving ability compared to 
the parent compounds without amino side chains, due to the favourable electrostatic 
interactions between the protonated amino group and the negatively charged 
phosphate backbone in DNA. So two aminomethylated Beaucage‟s reagents were 
synthesized to evaluate the effect of the amino side chain, and thiol-dependent DNA 
cleavage reaction were also done to investigate the efficiency of DNA cleaving 























Figure 4-3 Selected sulfur-containing organic molecules 
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The synthesis of aminomethylated Beaucage‟s reagent 4-1 and its sulfoxide 
analogue 4-2 is outlined in Scheme 4-2. The synthesis of 4-1 began with the 
diazonium reaction on 2-amino-3-methyl benzoic acid following the procedure 
described by Allen and coworkers.
218
 As the corresponding diazonium salt was 
unstable at elevated temperatures, the reaction temperature was strictly maintained 
below 5 C. Upon its formation, the salt was treated immediately with sulfide to 
generate disulfide under strongly alkaline conditions. Using activated zinc in 
refluxing glacial acetic acid, the disulfide bond was cleaved off to yield thiol 4-1a. 
The reaction of thioacetic acid with 4-1a in concentrated sulfuric acid gave rise to the 
cyclic compound 4-1b.
219
 Radical bromination at the benzylic position was performed 
by treating 4-1b with N-bromosuccinimide (NBS) and AIBN, yielding bromide 4-1c. 
The subsequent reaction of 4-1c with sodium azide in DMF then afforded the 
corresponding azide 4-1d in good yield. Attempts to synthesize the corresponding 
amine from 4-1d using triphenylphosphine following a typical Staudinger reduction 
220
 were unsuccessful. The Boc-protected product, 4-1e, was then obtained with an in 
situ procedure, 
221
 albeit in low yield. m-Chloroperoxybenzoic acid (m-CPBA) was 
used to accomplish the S-oxidation of 4-1e to produce the sulfoxide 4-1f.
222
 However, 
using a large excess of m-CPBA did not yield the corresponding sulfone.
223
 So an 
alternative approach was explored by employing dimethyldioxirane as potential 
oxidizing agent. A one-pot procedure in which Oxone™ was added to a solution of 
4-1e in acetone led to the successful preparation of the sulfone 4-1g. Finally, removal 
















   
 
Scheme 4-2 Synthesis of 4-1 and 4-2 Reagents and conditions: (a) i) 1 eq. NaNO2, conc. HCl, 0-5 
o
C; ii) 1.1 eq. Na2S, 1.1 eq. S8, NaOH, rt, 2 h; iii) 4 eq. Zn, CH3COOH, reflux, 16 h, 59 %; (b) 1 
eq. CH3COSH, conc. H2SO4, 50 
o
C, 2 h, 94 %; (c) 1.5 eq. NBS, 0.05 eq. AIBN, CCl4, Reflux, 
50 %; (d) 5 eq. NaN3, DMF, 60 
o
C, 16 h, 85 %; (e) 2.1 eq. Boc2O, 3 eq. K2CO3, 1.2 PPh3, CH2Cl2, 
rt, 19 h, 35 %; (f) 1.5 eq. m-CPBA, CH2Cl2, -20 
o
C, 24 h, 60 %; (g) 4 eq. Oxone , 12 eq. NaHCO3, 
acetone, 0 
o
C, 24 h, 80 %; (h) 10 eq. CF3COOH, CH2Cl2, rt, 12 h, 100 %. 
 
It was shown in the previous reports that Beaucage‟s reagent and other 
benzotrithiole 2-oxides could efficiently cause single-stranded breaks in duplex DNA 
in the presence of excess thiol, as measured by conversion of circular supercoiled 
DNA (form I) to circular relaxed (form II) DNA. The binding of substrates to DNA is 
believed to be strengthened by electrostatic interactions between the protonated amino 
side chain and the negatively charged phosphate backbone. 
  
4.3.2 Testing of DNA Cleavage Reaction 























































pBR322 with 1 were incubated and its concentrations were varied from 5 μM to 100 
μM, at pH 7.0 and in the presence of 2-mercaptoethanol, and the results are shown in 
Figure 4-4. 
 
Figure 4-4 Thiol-dependent DNA cleavage by 4-1 with various concentrations at pH 7.0. Assays 
were performed in 50 mM sodium phosphate buffer (pH 7.0) containing 0.5 g of supercoiled 
pBR322 DNA in the presence or absence of compound 4-1 and 2-mercaptoethanol (total volume 
20 L). The reaction time was 12 h. Lane 1, pBR322 DNA alone; Lane 2, pBR322 DNA with 4-1 
(5 M); Lane 3, 4-1 (5 M) + thiol (25 M); Lane 4, 4-1 (10 M) + thiol (50 M); Lane 5, 
pBR322 DNA with 4-1 (20 M) + thiol (100 M); Lane 6, pBR322 DNA with 4-1 (30 M) + 
thiol (150 M); Lane 7, pBR322 DNA with 4-1 (50 M) + thiol (250 M); Lane 8, pBR322 DNA 
with 4-1 (80 M) + thiol (400 M); Lane 9, pBR322 DNA with 4-1 (100 M). 
 
Similar to Beaucage‟s reagent, the DNA cleavage caused by 4-1 was also 
thiol-dependent. In the absence of thiol, compound 4-1 alone did not cause any DNA 
cleavage (Lanes 2 and 9). In the presence of thiol, sulfone 1 triggered DNA cleavage 
(Lanes 3 to 7). At a concentration of 80 μM (Lane 8), 1 led to very efficient cleavage 
of single-stranded DNA; the form I plasmid was almost completely converted to form 
II.  
The pH dependence of compound 1-triggered DNA cleavage was next examined, 
and plasmid pBR322 was incubated with 4-1 in different buffer solutions (pH ranging 
from 6 to 8). As shown in Figure 4-5, there was no significant enhancement on 
DNA-cleaving activities when the pH values were varied. These results are certainly 
very different from the varacin C-caused cleavage which could be effectively 
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promoted under acidic conditions.  
 
Figure 4-5 Thiol-dependent DNA cleavage by compound 4-1. Assays were performed in 50 mM 
sodium phosphate buffer with different pH containing 0.5 g of supercoiled pBR322 DNA in the 
presence or absence of compound 4-1 (50 M) and 2-mercaptoethanol (250 M). The total 
volume of reaction was 20 L. The reaction time was 12 h. Lane 1/2, pH 6.0 without/with thiol; 
Lane 3/4, pH 6.5 without/with thiol; Lane 5/6, pH 7.0 without/with thiol; Lane 7/8, pH 7.5 
without/with thiol; Lane 9/10, pH 8.0 without/with thiol. 
 
In order to achieve effective cleavage, reactions needed to be carried out for 12 
hours. Longer reaction time could lead to better yield of the cleaving products, but not 
very significantly (Figure 4-6). Reaction could be almost completed in 24 hours.  
 
 
Figure 4-6 Time dependence of DNA cleavage by compound 4-1 (30 M). Assays were 
performed in 50 mM sodium phosphate buffer (pH 7.0) containing 0.5 g of supercoiled pBR322 
DNA in the presence or absence of compound 4-1 and 2-mercaptoethanol (total volume 20 L). 
The reaction times corresponding to lanes 2 to 8 were 2, 4, 6, 8, 10, 12, 24 hours, respectively. 
  
The DNA-cleaving activities of sulfoxide 2 was also investigated (Figure 4-7). It 
was found that 4-2 was not an effective DNA-cleaving agent, even with concentration 
of 4-2 at 1 mM, no DNA cleavage was observed. This result suggested the presence of 
sulfone functional group, as well as disulfide bond, are important for the observed 
DNA-cleaving activities.  
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Figure 4-7 Thiol-dependent DNA cleavage by various concentrations of compound 4-2 compared 
to compound 4-1. Assays were performed in 50 mM sodium phosphate buffer (pH 7.0) containing 
0.5 g of supercoiled pBR322 DNA in the presence or absence of compound 4-1 and 
2-mercaptoethanol (total volume 20 L). The reaction time was 12 h. Lane 1, pBR322 DNA alone; 
Lane 2, pBR322 DNA with 4-2 (5 M) + thiol (25 M); Lane 3, 4-2 (100 M) + thiol (500 M); 
Lane 4, 4-2 (300 M) + thiol (1.5 mM); Lane 5, pBR322 DNA with 4-2 (1 mM) + thiol (5 mM); 
Lane 6, pBR322 DNA with 4-1 (5 M) + thiol (25 M); Lane 7, pBR322 DNA with 4-1 (100 M) 
+ thiol (500 M).  
  
Since compound 4-1 had shown great reactivity in catalyzing the thiol-dependent 
DNA cleavage reaction, next comparing effectiveness of compound 4-1 and 
Beaucage‟s reagent in causing DNA cleavage were carried out for experiment and the 
results are shown in Fig. 4-8, also quantifications of DNA cleavages are summarized 
in Table 4-1. The extents of DNA cleavage caused by aminomethylated Beaucage‟s 
reagent (4-1) with concentrations of 5 M, 30 M and 80 M are shown in lanes 2 to 
5, respectively. Cleavages of DNA by Beaucage‟s reagent are illustrated in lanes 7 to 
9, with concentrations of Beaucage‟s reagent at 50 M, 100 M and 250 M, 
respectively. Apparently, compound 4-1 is more efficient in causing DNA cleavage. In 
a quantitative comparison, compound 4-1 caused 76.6% cleavage of form I DNA at 
80 M (entry 5, Table 4-1), however, to reach similar level of cleavage (75.8%, entry 
9, Table 4-1), a 250 M of Beaucage‟s reagent needed to be used. These results 






Figure 4-8 Thiol dependent cleavage by various concentrations of 4-1 at pH 7.0 compared to 
Beaucage‟s reagent (BR) at different concentrations. Lane 1, pBR322 DNA alone; Lane 2, 
pBR322 DNA with 4-1 (80 M) without thiol; Lane 3, 4-1 (5 M) + thiol (25 M); Lane 4, 4-1 
(30 M) + thiol (150 M); Lane 5, pBR322 DNA with 4-1 (80 M) + thiol (400 M); Lane 6, 
pBR322 DNA with BR (250 M) but without thiol; Lane 7, pBR322 DNA with BR (50 M) + 
thiol (250 M); Lane 8, pBR322 DNA with BR (100 M) + thiol (500 M); Lane 9, pBR322 
DNA with BR (250 M) + thiol (1.25 mM). 
 





Entry I II % of I % of II 
1 95813 0 100 0 
2 149121 0 100 0 
3 150320 55233 73.1 26.9 
4 94991 109390 46.5 53.5 
5 45617 149348 23.4 76.6 
6 106179 0 100 0 
7 118073 109762 51.8 48.2 
8 68102 149350 31.3 68.7 
9 48113 150828 24.2 75.8 
 
a 
Quantification of extent of DNA cleavage was done by performing densitometric scanning to 
measure the volume of each band. The same experiment was repeated twice, seeing Supporting 
Information for the full details. 
 
4.3.3 Synthesis of Varacin B 
Another class of sulfur-containing cyclic organic compounds, varacin B was 
designed to synthesis. As a family member of varacin, varacin B was not fully studied 
as well as varacin C although the differences of two seemed to be very tiny. The total 
synthesis of varacin C was reported in 2002 
216
 and the examination of varacin C 
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revealed that it exhibited potent antifungal and antimicrobial activities against  
Staphylococcus aureus, Candida albicans and Bacillus subtilus. 
224
 In thiol 
dependent DNA cleavage reaction, varacin C has shown great reactivity, and the 
catalytic concentration could be decreased to micromolar scale. However, surprisingly, 
the synthesis of varacin B was not reported so far and the bioactivity of varacin B was 
not investigtated as well. In order to compare the difference of varacin B and varacin 
C based on their structures of 1-oxide and 3-oxide respectively, the total of varacin B 
was done and the exploration of DNA cleavage reaction was done as well. 
On the other hand, most tumor cells possess lower extracellular pH than that in 
normal tissue, an intrinsic feature of the tumor phenotype and is caused by alterations 
either in acid export or in clearance of extracellular acid.
313
 Antibiotics that possess 
acid-triggered functionalities are very rare in nature,
308
  
The synthetic routes leading to the synthesis of varacin B is illustrated in Scheme 
4-3, which was modified from the earlier reported procedures by Davidson,
225




5,6-Dibromovanillin 4-3b was prepared from vanillin 4-3a in the presence of 
bromine and ion power by refluxing condition. The yield of this single step was 70%. 
Compound 4-3c was obtained in 61% chemical yield by treatment of 4-3b with 
cuprous n-butylmercaptide in quinoline/pyridine at 160 
o
C. Next, 4-3c was further 
derived by methylation to give the intermediate 4-3d (65% yield) and followed by 
reaction in the condition of nitromethane/NH4OAc to gave nitrostyrene 4-3e in 78 % 
yield. After reduction of 4-3e with LiAlH4, the phenethylamine side chain was 
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obtained, then protected with tert-butoxycarbonyl (Boc) group, to give 4-3g in 65% 
chemical yield from 4-3e. The n-butyl groups could be deprotected in the Na/NH3 
condition to get the free dithiol groups. After treatment with dimethyltin dichloride 
which was considered to activate two free dithiol groups, dithiolate anion 4-3i was 
formed. Upon addition of thionyl chloride, 4-3j was obtained in 28 % chemical yield 
for three steps. A novel UV-induced isomerization was occurred to give a mixture of 
the corresponding 4-3k and 4-3l. The UV condition was followed by that in Sato‟s 
report (Scheme 4-4).
226 
After removal of the Boc group with TFA in dichloromethane 












































































































































Scheme 4-4 UV-induced isomerization 
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In the UV-induced isomerization reaction, the mechanism of oxygen shifting in 
trithiole 2-oxide ring could be followd by photochemical rearrangements without ring 
opening (Scheme 4-5). Benzotrithiole 2-oxide is first photolysed to form singlet 
excited 4-5, which is rapidly transformed into the strained intermediate A. According 
to path a and path b, intermediate A could convert into benzotrithiole 1-oxide 4-6 and 
back to the 2-oxide 4-5, respectively. The rate of quenching of singlet excited 4-6 is 
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4.3.4 DNA-Cleaving Activities of Varacin B  
The DNA-cleaving activity of varacin B was examined by monitoring its 
effectiveness in converting circular supercoiled DNA (form I) to the corresponding 
circular nicked form (form II). Plasmid pBR322 was used the same as that in the 
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Scheme 4-6 The conversion of circular supercoiled DNA 
 
The discovery of the DNA-cleaving activities of varacin C revealed that 
thiol-dependent DNA cleavage reaction could efficiently occur in the acid condition, 
which could be considered as a good sign for the further exploration of other 
biological activities. Because usually, most tumor cells possess lower extracellular pH 
than that in normal tissue, an intrinsic feature of the tumor phenotype and is caused by 
alterations either in acid export or in clearance of extracellular acid.
227
  
As shown in Figure 4-9, different pH values of phosphate buffer were used in the 
the thiol dependent DNA cleavage reaction. It was shown that by decreasing pH value 
of phosphate buffer, the amount of DNA cleavage by varacin B increases. At pH 5.5, 
the cleavage reaction could perform better, thus obtaining more amounts of form II 
(85%, lane 2). It was proven that the reaction could be accelerated in the acidic 
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condition so the pH value 5.5 was chose as the necessary reaction condition for 
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Figure 4-9 Acid-promoted DNA cleavage by varacin B in sodium phosphate buffer solutions at 
various pH values. Reactions were incubated at 37 °C for 12 h in 50 mM sodium phosphate 
containing 10% (v/v) acetonitrile, 500 ng of supercoiled pBR322 DNA and in the presence or 
absence of varacin B and 1 mM 2-mercaptoethanol activating reagents; lane 1, pH 5.5, no added 
thiol and varacin B; lane 2, pH 5.5, 150 nM varacin B and 1 mM 2-mercaptoethanol; lane 3, pH 
6.0, no added thiol and varacin B; lane 4, pH 6.0, 150 nM varacin B and 1 mM 2-mercaptoethanol; 
lane 5, pH 6.5, no added thiol and varacin B; lane 6, pH 6.5, 50 nM varacin B and 1 mM 
2-mercaptoethanol; lane 7, pH 7.0, no added thiol and varacin B; lane 8, pH 7.0, 150 nM varacin 
B and 1 mM 2-mercaptoethanol; lane 9, pH 7.5, no added thiol and varacin B; lane 10, pH 7.5, 
150 nM varacin B and 1 mM 2-mercaptoethanol. 
 
Various concentrations of varacin B under pH 5.5 conditions were tested. As 
agarose gel shown in Figure 4-10, with the increasing the concentrations of varacin B, 
the amount of DNA cleavage could also increase. It was found that the concentration 
of varacin B could be as low as 10 nM at pH 5.5 (lane 2) to produce the relaxed form 
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Figure 4-10 Acid-promoted DNA cleavage by various concentrations of varacin B. Reactions 
were incubated at 37 °C for 12 h in 50 mM sodium phosphate (pH 5.5) containing 10% (v/v) 
acetonitrile, 500 ng supercoiled pBR322 DNA, varacin B and 1 mM 2-mercaptoethanol; Lane 1, 
pBR322 alone; lane 2, 10 nM varacin B; lane 3, 25 nM varacin B; lane 4, 50 nM varacin B; lane 5, 
75 nM varacin B; lane 6, 100 nM varacin B; lane 7, 150 nM varacin B; lane 8, 200 nM varacin B. 
 
Last, different types of nucleophiles were used to further explore the reaction 
mode of DNA cleavage. The results are shown in Figure 4-11. The DNA-cleavage by 
varacin B did not occur when thiol was abscent in the reaction (lane 1). In addition, 
glutathione and cysteine were both capable of triggering varacin B-mediated DNA 
cleavage as effectively as 2-mercaptoethanol (lanes 4 and 6). However, phenol or 
aniline did not promote the DNA cleavage reaction as shown in lane 8 and 10 below. 
 
 
Figure 4-11 Activation of varacin B-promoted DNA cleavage by various nucleophiles. Reactions 
were incubated at 37 °C for 6 h in 50 mM sodium phosphate (pH 5.5) containing 10% v/v 
acetonitrile, 500 ng of supercoiled pBR322 DNA, 200 nM varacin B and in the presence or 
absence of nucleophile; lane 1, no added 2-mercaptoethanol; lane 2, 1 mM 2-mercaptoethanol; 
lane 3, no added glutathione; lane 4, 1 mM glutathione; lane 5, no added cysteine; lane 6, 1 mM 
cysteine; lane 7, no added 4-ethylphenol; lane 8, 1 mM 4-ethylphenol; lane 9, no added 
4-methylaniline; lane 10, 1 mM 4-methylaniline. 
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4.4 Conclusion 
In conclusion, two classes of sufur-containing cyclic organic compounds were 
synthesized. For disulfide-derived Beaucage‟s reagent analogue, aminomethylated 
Beaucage‟s reagent 4-1, and its sulfoxide analogue 4-2 were successfully synthesized . 
The DNA-cleaving activities of 4-1 and 4-2 have been investigated by examining 
their effectiveness in converting circular supercoiled DNA (form I) to the 
corresponding circular nicked form (form II). The presence of amino side chain in 4-1 
improved its DNA cleaving activity, leading to substantial potency improvement 
comparing to its non-amino analogue (3H-1,2-benzodithiol-3-one 1-oxide). The 
sulfoxide 4-2, however, was found to be ineffective in cleaving DNA. The results 
suggested that combination of the amino group and sulfur-containing DNA-cleaving 
functionality could lead to the generation of novel effective DNA-cleaving agents, 
which may find potential applications in anti-cancer research.  
For trithiol-derived cyclic organic compounds, varacin B were successfully 
synthesized and biological test methods of varacin B for the DNA cleavage reaction 
were developed compared with that of varacin C. The test results of acid-promoted 
DNA-cleaving activities of natural varacin B strongly support that it possess novel, 
important DNA cleavage abilities, and it also sheds the light on the development of 
anti-cancer agents by further modification and optimization of these sulfur-containing  
cyclic organic compounds 
Further investigation to understand the origin of observed DNA-cleavage and to 
search for more potent sulfur-containing DNA-cleaving functionalities are in 
progress. 
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4.5 Experimental Section                       
4.5.1 General Information 





C NMR spectra were recorded on a Bruker ACF300 or DPX300 
(300 MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts are reported in 
parts per million (ppm), and the residual solvent peak was used as an internal 
reference: proton (chloroform  7.26), carbon (chloroform  77.0). Multiplicity is 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants are reported in Hertz 
(Hz). Low resolution mass spectra were obtained on a Finnigan/MAT LCQ 
spectrometer in ESI mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB 
mode. All high resolution mass spectra were obtained on a Finnigan/MAT 95XL-T 
spectrometer. For thin-layer chromatography (TLC), Merck pre-coated TLC plates 
(Merck 60 F254) was used, and compounds were visualized with a UV light at 254 nm. 
Further visualization was achieved by staining with iodine, or ceric ammonium 
molybdate followed by heating on a hot plate. Flash chromatography separations 
were performed on Merck 60 (0.040 - 0.063 mm) mesh silica gel. Microwave 
irradiation was performed using a CEM Discover Synthesis Unit with a 0.5-2 





4.5.2 Materials  
All reagents and chemicals were purchased from Sigma-Aldrich Chemical Co. 
and used as received, unless otherwise stated. Handheld UV Lamp (Brand: Uvitec, 
UK; Model: LF 106L) used in our studies was purchased from its Science and 
Medical Pte. Ltd. Bromine was purchased from VWR Singapore Pte Ltd. THF was 
distilled over sodium wire under nitrogen atmosphere before use. Dichloromethane 
(DCM) and triethylamine (Et3N) were distilled over calcium hydride prior to use. 
The pBR322 DNA was purchased from New England Biolabs (Cat. Number: 
N3033L, 1,000 μg/mL in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0 at 25 oC). This DNA 
is isolated from E. coli ER2272 by a standard plasmid purification procedure, and 
should be stored at -20 
o
C. It is a commonly used plasmid cloning vector in E. coli.
228
 
It contains a double-stranded circle 4,361 base pairs in length.
229
 pBR322 contains the 
genes for resistance to ampicillin and tetracycline, and can be amplified with 






4.5.3 General Methods 
Analytical thin-layer chromatography (TLC) was carried out on Whatman TLC 
plates precoated with silica gel 60 (Merck 60 F254). Visualization was performed using 
a UV lamp (λ= 254 nm). Column chromatography was performed on Merck silica gel 
(230-400 mesh) eluting with ethyl acetate and hexane, using compressed air. 
All DNA-cleaving reactions by aminomethylated Beaucage‟s reagent (4-1) and 
varacin B were analyzed by electrophoresis on 1% agarose gels in 1 M Tris-acetaed 
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buffer (100 v, 2 h). The resulting gels were subsequently photographed on a UV 
trans-illuminator after attaining with ethidium bromide. The amount of DNA in each 
band of ethidium-stained gels was quantified using Lumi-Imager (LumiAnalyst 3.1). 
General procedures for preparation of 1% agarose gel electrophorosis 
1) Prepare 1x TBE (Prepared from the 10x stock).  
2) 1g of agarose was added into the conical flask and 100 mL 1x TBE was added 
subsequently. 
3) Heat the solution to boiling to dissolve the agarose. 
4) Add 5 μl of ethidium bromide to the dissolved agarose and mix.  
5) Get a gel plate and a comb. Put the two dams into the slots on each side of the gel 
plate. Make sure that they fit tight. Pour the melted agarose onto the gel plate in the 
Agarose gel electrophoresis box. Next, place the comb (well-maker) with teeth in 
place. 
6) Let the gel cool to room temperature. 
 






























































Scheme 4-2 Synthesis of 4-1 Reagents and conditions: (a) i) 1 eq. NaNO2, conc. HCl, 0-5 
o
C; ii) 
1.1 eq. Na2S, 1.1 eq. S8, NaOH, rt, 2 h; iii) 4 eq. Zn, CH3COOH, reflux, 16 h, 59 %; (b) 1 eq. 
CH3COSH, conc. H2SO4, 50 
o
C, 2 h, 94 %; (c) 1.5 eq. NBS, 0.05 eq. AIBN, CCl4, Reflux, 50 %; 
(d) 5 eq. NaN3, DMF, 60 
o
C, 16 h, 85 %; (e) 2.1 eq. Boc2O, 3 eq. K2CO3, 1.2 PPh3, CH2Cl2, rt, 19 
h, 35 %; (f) 1.5 eq. m-CPBA, CH2Cl2, -20 
o
C, 24 h, 60 %; (g) 4 eq. Oxone , 12 eq. NaHCO3, 
acetone, 0 
o
C, 24 h, 80 %; (h) 10 eq. CF3COOH, CH2Cl2, rt, 12 h, 100 %. 
 
2-Mercapto-3-benzoic acid (4-1a)  
To a mixture of 2-amino-3-methyl-benzoic acid (0.30 g, 1.98 mmol), water (1 
mL) and concentrated HCl (0.4 mL) at 0 C, was added a pre-cooled solution of 
NaNO2 (0.14 g, 1.98 mmol) in water (0.5 mL). The diazonium salt solution was tested 
with starch-iodine paper and a blue coloration was observed. Na2S·9 H2O (0.52 g, 
2.18 mmol)  and powdered sulfur (0.067 g, 2.18 mmol) were dissolved in boiling 
water (2 mL), a solution of 10 M NaOH (0.2 mL) was then added and the resulting 
yellow solution was cooled in an ice bath. Along with crushed ice, the diazonium 
solution was added to the stirred alkaline sulfide solution over 30 minutes. The 
temperature of the reaction mixture as kept below 5 C by directly adding ice. The 
mixture was allowed to warm up to room temperature and stirred for another 2 hours. 
Concentrated HCl solution (0.24 ml) was added to adjust the pH of solution to 3. The 
precipitate was filtered, and washed with water.  To further remove excess sulfur, the 
precipitate was boiled in a solution of Na2CO3 (0.12 g) in water (4 mL), and the 
mixture was filtered off while hot. The pH of the filtrate was adjusted to 3, and the 
precipitate was filtered, and washed with water. The crude disulfide was then mixed 
with zinc dust (0.5 g, 7.69 mmol) and glacial acetic acid (1 mL), and the mixture was 
brought to reflux for 16 h.  After cooling down to room temperature, the mixture was 
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filtered, and the precipitate was washed with water, and then suspended in water (5 
mL). An aqueous solution of 33 % NaOH (0.08 mL) was added, and the mixture was 
boiled for 20 min to ensure complete extraction of product from the precipitate. After 
filtration, concentrated HCl was added to the filtrate, and the precipitate was collected 
and washed with water to afford desired 4-1a as a pale pink powder (0.20 g, 59%)  
1
H NMR (CDCl3, 300 MHz)  = 2.43 (s, 3H), 6.60 (s, 1H), 7.13 (t, 1H, J = 7.7 Hz), 
7.40 (d, 1H, J = 7.4 Hz), 8.08 (d, 1H, J = 8.0 Hz); 
13
C NMR (CDCl3, 75 MHz)  = 





 167.0172, found 167.0141; m.p. 195.0 C. 
 
7-Methyl-3H-benzo[c][1,2]dithiol-3-one (4-1b) 
To a suspension of 4-1a (0.14 g, 0.82 mmol) in concentrated H2SO4 (2 mL) at 
ambient temperature was added thioacetic acid (0.12 ml, 1.64 mmol) dropwise over a 
period of 40 minutes. The mixture was heated at 50 C for 2 h, and then quenched by 
pouring the mixture onto crushed ice (300 g). The precipitate was filtered through a 
Büchner funnel, thoroughly washed with water and suspended in chloroform (10 mL). 
The mixture was shaken with saturated aqueous sodium bicarbonate (5 mL), and solid 
was filtered and triturated in boiling chloroform several times, and the organic layers 
were combined. The organic phase was washed with saturated sodium bicarbonate (10 
mL) and water (2 x 10 mL), and dried over anhydrous magnesium sulfate. After 
filtration and concentration, the crude was purified by column chromatography 
(EtOAc/hexane 1:3) to afford 4-1b as a yellow needle (0.140 g, 94%) 
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1
H NMR (CDCl3, 300 MHz)  = 2.49 (s, 3H), 7.35 (t, 1H, J = 7.6 Hz), 7.47 (d, 1H, J 
= 7.1 Hz), 7.80 (d, 1H, J = 7.9 Hz); 
13
C NMR (CDCl3, 75 MHz)  = 18.4, 124.9, 
125.9, 129.0, 133.6, 133.9, 147.9, 194.0; HRMS (EI) calcd for C8H6O1
32
S2 181.9860, 
found 181.9865; m.p. 96.0 – 97.0 C. 
 
7-(Bromomethyl)-3H-benzo[c][1,2]dithiol-3-one (4-1c)  
To a solution of 4-1b (0.14 g, 0.746 mmol) in CCl4 (5 mL) were added 
N-bromosuccinimide (0.20 g, 1.59 mmol) and AIBN (6 mg, 0.036 mmol). The 
reaction mixture was then brought to reflux for 24 h, and quenched by adding cold 
water. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 
x 10 mL). The combined organic extracts were dried over anhydrous MgSO4, filtered 
and concentrated in vacuo. The crude was purified by column chromatography 
(EtOAc/hexane 1:20) to give 4-1c as a pale yellow needle (0.097 g, 50%). 
1
H NMR (CDCl3, 300 MHz)  = 4.63 (s, 2H), 7.40 (t, 1H, J = 7.9 Hz), 7.67 (d, 1H, J 
= 7.9 Hz), 7.89 (d, 1H, J = 7.9 Hz); 
13
C NMR (CDCl3, 75 MHz)  = 28.6, 126.3, 









S2 261.8945, found 261.8942; m.p .119.0 – 
120.0 C. 
 
7-(Azidomethyl)-3H-benzo[c][1,2]dithiol-3-one (4-1d)  
To a solution of 4-1c (0.25 g, 0.960 mmol) in DMF (3 mL) was added NaN3 
(0.310 g, 4.79 mmol), and the resulting mixture was stirred at 60 C for 24 h. The 
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solvent was removed under reduced pressure, and the residue was dissolved in 
CH2Cl2 (20 mL). The organic phase was washed with water (3 x 15 mL), and dried 
over anhydrous MgSO4. After filtration and concentration in vacuo, the crude was 
purified by column chromatography (EtOAc/hexane 1:4) to give 4-1d as a white solid 
(0.182 g, 85%). 
1
H NMR (CDCl3, 300 MHz)  = 4.63 (s, 2H), 7.48 (t, 1H, J = 7.7 Hz), 7.67 (d, 1H, J 
= 7.2 Hz), 7.97 (d, 1H, J = 7.9 Hz); 
13
C NMR (CDCl3, 75 MHz)  = 52.0, 126.1, 
127.5, 130.2, 131.8, 133.0, 147.2, 193.2; HRMS (EI) calcd for C8H5O1N3
32
S2 
222.9874, found 222.9872; m.p. 62.0 – 63.0 C. 
 
tert-Butyl (3-oxo-3H-benzo[c][1,2]dithiol-7-yl)methylcarbamate (4-1e)  
To a solution of 4-1d (0.11 g, 0.490 mmol) in CH2Cl2 (6 mL) were added PPh3 
(0.15 g, 0.588 mmol), Boc2O (0.23 g, 1.03 mmol), K2CO3 (0.20 g, 1.76 mmol) and 
water (2 mL), the reaction mixture was stirred at room temperature for 24 hours. The 
organic and aqueous phases were separated and the aqueous layer was extracted with 
CH2Cl2 (2 x 5 mL). The combined organic extracts were washed with brine (1 x 15 
mL), and dried over anhydrous MgSO4, filtered and concentrated in vacuo. The 
residue was purified by column chromatography (EtOAc/hexane 1:6) to give 4-1e as a 
white solid (0.050 g, 35%) 
1
H NMR (CDCl3, 300 MHz)  = 1.49 (s, 9H), 4.53 (d, 2H, J = 5.9 Hz), 5.15 (s, 1H), 
7.41 (t, 1H, J = 7.6 Hz), 7.62 (d, 1H, J = 7.2 Hz), 7.87 (d, 1H, J = 7.9 Hz); 
13
C NMR 
(CDCl3, 75 MHz)  = 28.3, 42.2, 80.2, 126.0, 126.4, 129.8, 132.1, 134.9, 146.5, 155.6, 
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193.6; HRMS (EI) calcd for C13H15O3N1
32
S2 297.0493, found 297.0494; m.p. 96.0 – 
97.0 C. 
 
7-(N-Boc-aminomethyl)-3H-benzo[c][1,2]dithiol-3-one 1-oxide (4-1f)  
To a stirred solution of 4-1e (0.020 g, 0.067 mmol) in CH2Cl2 (2 mL) at -20 C 
was added slowly a solution of m-chloroperoxybenzoic acid (0.040 g, 0.202 mmol) in 
CH2Cl2 (2 mL). The mixture was kept stirring at below -30 C for 45 minutes, and 
then at room temperature for 24 hours. The reaction mixture was diluted with CH2Cl2 
and washed with aqueous Na2S2O3 (2 x 5 mL) and NaHCO3 (1 x 5 mL). The organic 
phase was concentrated in vacuo and purified by column chromatography 
(EtOAc/hexane 1:5) to give 4-1f as a white solid (0.013 g, 60%). 
1
H NMR (CDCl3, 300 MHz)  = 1.47 (s, 9H), 4.52 (d, 2H, J = 5.9 Hz), 4.99 (s, 1H), 
7.41 (t, 1H, J = 7.9 Hz), 7.61 (d, 1H, J = 6.8 Hz), 7.88 (d, 1H, J = 7.9 Hz); 
13
C NMR 
(CDCl3, 75 MHz)  = 28.4, 42.3, 80.4, 126.1, 126.6, 129.9, 132.2, 135.0, 146.7, 155.6, 




Na1 336.0335, found 336.0323; m.p. 
94.0 – 95.0 C. 
 
7-(N-Boc-aminomethyl)-3H-benzo[c][1,2]dithiol-3-one 1,1-dioxide (4-1g)  
To a stirred solution of 4-1e (10 mg, 0.034 mmol) in acetone (1.5 mL) at 0 C 
was added Oxone™ (83 mg, 0.135 mmol) and NaHCO3 (33.6 mg, 0.404 mmol) over 
20 minutes. The reaction mixture was then allowed to warm up to room temperature. 
Upon completion of reaction as judged by TLC, solvent was removed in vacuo. The 
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residue was taken up in CH2Cl2, and the mixture was filtered. Concentration of the 
filtrate under reduced pressure yielded 4-1g as a white solid (9 mg, 80%). 
1
H NMR (CDCl3, 300 MHz)  = 1.43 (s, 9H), 4.57 (dd, 1H, J = 4.6 Hz and 15.6 Hz), 
4.90 (dd, 1H, J = 7.7 Hz and 15.5 Hz), 5.27 (s, 1H), 7.77 (t, 1H, J = 7.6 Hz), 7.93 (m, 
2H); 
13
C NMR (CDCl3, 75 MHz)  = 28.4, 41.4, 80.6, 126.6, 129.9, 130.3, 131.9, 
134.0, 136.6, 140.8, 192.7; HRMS (IT-TOF) calcd for C13H15O5N1
32
S2Na1 352.0289, 
found 352.0254; m.p. 192 .0 C. 
 
7-(Aminomethyl)-3H-benzo[c][1,2]dithiol-3-one 1-oxide (4-2)  
To a solution of 4-1f (15 mg, 0.051 mmol) in CH2Cl2 (10 mL) was added 
CF3COOH, and the resulting solution was stirred at room temperature for 12 hours. 
The reaction mixture was concentrated under reduced pressure and co-evaporated 
with CH2Cl2 several times to afford 4-2 as pale yellow syrup (10 mg, 100 %).  
 
7-(Aminomethyl)-3H-benzo[c][1,2]dithiol-3-one 1,1-dioxide (4-1)  
A light yellow powder; 
1
H NMR (CD3OD, 300 MHz)  = 4.64 (dd, J = 14.5 Hz and 
26.6 Hz), 8.00 (t, 1H, J = 7.6 Hz), 8.10 (m, 2H); 
13
C NMR (CD3OD, 75 MHz)  = 
















                                                                                                                         





Figure 4-4 Thiol-dependent DNA cleavage by 4-1 with various concentrations at pH 7.0. Assays 
were performed in 50 mM sodium phosphate buffer (pH 7.0) containing 0.5 g of supercoiled 
pBR322 DNA in the presence or absence of compound 4-1 and 2-mercaptoethanol (total volume 
20 L). The reaction time was 12 h. Lane 1, pBR322 DNA alone; Lane 2, pBR322 DNA with 4-1 
(5 M); Lane 3, 4-1 (5 M) + thiol (25 M); Lane 4, 4-1 (10 M) + thiol (50 M); Lane 5, 
pBR322 DNA with 4-1 (20 M) + thiol (100 M); Lane 6, pBR322 DNA with 4-1 (30 M) + 
thiol (150 M); Lane 7, pBR322 DNA with 4-1 (50 M) + thiol (250 M); Lane 8, pBR322 DNA 






                                                                                                                       




Figure 4-5 Thiol-dependent DNA cleavage by compound 4-1. Assays were performed in 50 mM 
sodium phosphate buffer with different pH containing 0.5 g of supercoiled pBR322 DNA in the 
presence or absence of compound 4-1 (50 M) and 2-mercaptoethanol (250 M). The total 
volume of reaction was 20 L. The reaction time was 12 h. Lane 1/2, pH 6.0 without/with thiol; 
Lane 3/4, pH 6.5 without/with thiol; Lane 5/6, pH 7.0 without/with thiol; Lane 7/8, pH 7.5 














                                                                                                                       





Figure 4-6 Time dependence of DNA cleavage by compound 4-1 (30 M). Assays were 
performed in 50 mM sodium phosphate buffer (pH 7.0) containing 0.5 g of supercoiled pBR322 
DNA in the presence or absence of compound 4-1 and 2-mercaptoethanol (total volume 20 L). 
The reaction times corresponding to lanes 2 to 8 were 2, 4, 6, 8, 10, 12, 24 hours, respectively. 
 
 










Figure 4-7 Thiol-dependent DNA cleavage by various concentrations of compound 4-2 compared 
to compound 4-1. Assays were performed in 50 mM sodium phosphate buffer (pH 7.0) containing 
0.5 g of supercoiled pBR322 DNA in the presence or absence of compound 4-1 and 
2-mercaptoethanol (total volume 20 L). The reaction time was 12 h. Lane 1, pBR322 DNA alone; 
Lane 2, pBR322 DNA with 4-2 (5 M) + thiol (25 M); Lane 3, 4-2 (100 M) + thiol (500 M); 
Lane 4, 4-2 (300 M) + thiol (1.5 mM); Lane 5, pBR322 DNA with 4-2 (1 mM) + thiol (5 mM); 
Lane 6, pBR322 DNA with 4-1 (5 M) + thiol (25 M); Lane 7, pBR322 DNA with 4-1 (100 M) 
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Figure 4-8 Thiol dependent cleavage by various concentrations of 4-1 at pH 7.0 compared to 
Beaucage‟s reagent (BR) at different concentrations. Lane 1, pBR322 DNA alone; Lane 2, 
pBR322 DNA with 4-1 (80 M) without thiol; Lane 3, 1 (5 M) + thiol (25 M); Lane 4, 4-1 (30 
M) + thiol (150 M); Lane 5, pBR322 DNA with 4-1 (80 M) + thiol (400 M); Lane 6, 
pBR322 DNA with BR (250 M) but without thiol; Lane 7, pBR322 DNA with BR (50 M) + 
thiol (250 M); Lane 8, pBR322 DNA with BR (100 M) + thiol (500 M); Lane 9, pBR322 
DNA with BR (250 M) + thiol (1.25 mM). 
 
4.5.6 Quantifications of Extents of Cleavages by 4-1 and 4-2 
 







 Sum intensity   Sum intensity       

















1 116408 0 100 0 168814 0 100 0 100 0 0 0 
2 119369 0 100 0 165865 0 100 0 100 0 0 0 
3 192432 27148 87.6 12.4 166339 18114 90.2 9.8 88.9 11.1 1.8 1.8 
4 194185 58639 76.8 23.2 133427 18908 87.6 12.4 82.2 17.8 7.6 7.6 
5 132248 66976 66.4 33.6 211213 54324 79.5 20.5 73.0 27.0 9.3 9.3 
6 109848 106571 50.8 49.2 166993 149468 52.8 47.2 51.8 48.2 1.4 1.4 
7 65937 118751 35.7 64.3 97974 140493 41.1 58.9 38.4 61.6 3.8 3.8 
8 40351 130613 23.6 76.4 19609 166285 10.5 89.5 17.1 82.9 9.2 9.2 
9 118619 0 100.0 0.0 374249 0 100 0 100 0 0 0 
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Table 4-3 quantifications of thiol-dependent DNA cleavage by compound 4-1 
 
 














 Sum intensity   Sum intensity       

















1 135986 10053 93.1 6.9 80858 0 100 0 96.6 3.4 4.87 4.87 
2 113579 20520 84.7 15.3 35142 35424 49.8 50.2 67.2 32.8 24.68 24.68 
3 129394 0 100.0 0.0 93217 0 100.0 0.0 100.0 0.0 0.00 0.00 
4 125688 25608 83.1 16.9 33404 46735 41.7 58.3 62.4 37.6 29.27 29.27 
5 113337 4332 96.3 3.7 88295 0 100.0 0.0 98.2 1.8 2.60 2.60 
6 64548 33348 65.9 34.1 28518 37958 42.9 57.1 54.4 45.6 16.29 16.29 
7 78943 0 100.0 0.0 97602 0 100.0 0.0 100.0 0.0 0.00 0.00 
8 30514 30445 50.1 49.9 40834 63367 39.2 60.8 44.6 55.4 7.69 7.69 
9 93515 0 100.0 0.0 103124 0 100.0 0.0 100.0 0.0 0.00 0.00 
10 28355 29734 48.8 51.2 33233 53280 38.4 61.6 43.6 56.4 7.35 7.35 
 Sum intensity   Sum intensity       

















1 163532 0 100 0 113394 0 100 0 100.0 0.0 0.00 0.00 
2 62503 0 100.0 0.0 104938 0 100.0 0.0 100.0 0.0 0.00 0.00 
3 108855 0 100.0 0.0 58072 0 100.0 0.0 100.0 0.0 0.00 0.00 
4 162707 0 100.0 0.0 62278 8809 87.6 12.4 93.8 6.2 8.76 8.76 
5 147879 23650 86.2 13.8 68718 46950 59.4 40.6 72.8 27.2 18.95 18.95 
6 55494 25456 68.6 31.4 35986 69861 34.0 66.0 51.3 48.7 24.43 24.43 
7 38632 60707 38.9 61.1 15421 37356 29.2 70.8 34.1 65.9 6.84 6.84 
8 27417 150350 15.4 84.6 10833 45351 19.3 80.7 17.4 82.6 2.73 2.73 
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Table 4-5 quantifications of various concentrations of 4-1 at pH 7.0 compared to 














 Sum intensity   Sum intensity       
  I II 
% 
of I  
% 
of II  I II 
% 
of I  
% 









1 391198 0 100 0 95813 0 100 0 100.0 0.0 0.00 0.00 
2 352192 0 100 0 149121 0 100 0 100.0 0.0 0.00 0.00 
3 269758 135568 66.6 33.4 150320 55233 73.1 26.9 69.8 30.2 4.65 4.65 
4 158716 176404 47.4 52.6 94991 109390 46.5 53.5 46.9 53.1 0.62 0.62 
5 57741 149861 27.8 72.2 45617 149348 23.4 76.6 25.6 74.4 3.12 3.12 
6 123395 0 100 0 106179 0 100 0 100.0 0.0 0.00 0.00 
7 196990 122179 61.7 38.3 118073 109762 51.8 48.2 56.8 43.2 7.00 7.00 
8 142584 154397 48.0 52.0 68102 149350 31.3 68.7 39.7 60.3 11.80 11.80 
9 44269 172340 20.4 79.6 48113 150828 24.2 75.8 22.3 77.7 2.65 2.65 
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Compound 4-3b: a pink solid; 62% yield; 
1
H NMR (300 MHz, DMSO-D6) δ = 3.89 (s, 
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3H, OCH3), 7.38 (s, 1H, ArH),10.06 (s, 1H, CHO); 
13
C NMR (75 MHz, DMSO-D6) δ 
= 191.0, 151.4, 147.6, 126.3, 122.3, 113.9, 110.5, 56.5; MS (ESI) calcd for 
[C8H7Br2O3]
+








Compound 4-3c: a yellow solid; 65% yield; 
1
H NMR (300 MHz, CDCl3) δ = 
0.86-0.88 (m, 6H, 2CH3), 1.39-1.54 (m, 8H, 2CH2CH2), 2.84-2.87 (m, 4H, 2SCH2), 
3.95 (s, 3H, OCH3), 7.47 (s, 1H, ArH), 10.68 (s, 1H, CHO); 
13
C NMR (75 MHz, 
CDCl3) δ = 192.2, 152.8, 147.9, 129.4, 127.8, 126.5, 121.1, 110.7, 56.2, 38.7, 36.3, 
31.6, 31.4, 21.9, 13.6; MS (ESI) calcd for [C16H23S2O3]
-








Compound 4-3d: an orange syrup; 71% yield; 
1
H NMR (300 MHz, CDCl3) δ = 
0.86-0.88 (m, 6H, 2CH3), 1.39-1.52 (m, 8H, 2CH2CH2), 2.82-2.99 (m, 4H, 2SCH2), 
3.93 (s, 6H, 2OCH3), 7.43 (s, 1H, ArH), 10.74 (s, 1H, CHO); 
13
C NMR (75 MHz, 
CDCl3) δ = 192.9, 155.3, 153.5, 137.3, 135.5, 110.4, 60.4, 56.0, 38.3, 35.3, 31.9, 31.4, 
22.0, 13.6; MS (ESI) calcd for [C17H27S2O3]
+










A mixture of 2,3-bis(n-butylthio)-4,5-dimethoxybenzaldehyde 4-3d (0.177 g, 0.5 
mmol), nitromethane (5 mL), glacial acetic acid (0.074 mL, 1.25 mmol) and NH4OAc 
(0.0794 g, 1.03 mmol) was heated and kept the temperature 60 
o
C for 8 hours 
followed by the addition of ice water (15 mL) to quench the reaction. After extraction 
of the aqueous mixture with diethyl ether, the combined organic phase was washed 
with water and brine and dried over Na2SO4. After removal of solvent under reduced 
pressure, the crude product was purified by flash chromatography on silica gel eluting 
with hexane:ethyl acetate (5:1, v/v) to afford 4-3e (0.1657 g, 86% yield) as an 
yellow/brown oil. 
Compound 4-3e: an yellow oil; 86% yield; 
1
H NMR (300 MHz, CDCl3) δ = 
0.86-0.88 (m, 6H, 2CH3), 1.39-1.49 (m, 8H, 2CH2CH2), 2.78-3.00 (m, 4H, 2SCH2), 
3.92 (s, 6H, 2OCH3), 6.99 (s, 1H, ArH), 7.45-7.49 (d, J = 13.8 Hz, 1H, CH), 8.89-8.93 
(d, J = 13.7 Hz, 1H, CH); 
13
C NMR (75 MHz, CDCl3) δ = 153.4, 139.1, 137.6, 134.2, 














To a slurry of LAH (0.32 g, 8.43 mol) in distilled THF (10 mL) was added a 
solution of 4-3e (0.9208 g, 2.39 mmol) in THF (10 mL). The mixture was heated at 
reflux for 1.5 h followed by cooling the reaction to 4 
0
C in an ice water bath. After the 
addition of 15% v/v aqueous HCl, the aqueous mixture was extracted with ethyl 
acetate. The combined organic extracts were washed with water and brine and dried 
over Na2SO4. Removal of solvent under reduced pressure afforded the crude amine 
salt (0.8916 g) as a yellow syrup, which was used without further purification. 
 







Compound 4-3g: an orange syrup; 35% yield for two steps; 
1
H NMR (300 MHz, 
CDCl3) δ = 0.84-0.86 (m, 6H, 2CH3), 1.32-1.61 (m, 17H, 2CH2CH2, 3CH3), 2.74-2.97 
(m, 4H, 2SCH2), 2.98-3.32 (m, 4H, CH2CH2), 3.80 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 
6.72 (s, 1H, ArH); 
13
C NMR (75 MHz, CDCl3) δ = 155.8, 152.9, 148.9, 140.1, 136.5, 












Liquid ammonia was condensed by means of a dry-ice condenser into a 50 mL 
two-necked round bottom flask containing small pieces of sodium metal (about 0.8 g). 
A solution of 4-3g (0.3805 g, 0.83 mmol) in distilled THF (10 mL) was injected in 
this round bottom flask at -78 
0
C to -60 
0
C when a deep blue solution persisted. After 
stirring for 1 h, the reaction was quenched by the addition of solid NH4Cl. The excess 
ammonia was allowed to evaporate under a stream of N2. The resultant white residue 
was dissolved in water and acidified with 15% (v/v) aqueous HCl. After extraction of 
the aqueous solution with DCM, the combined organic extracts were washed with 
water and brine and dried over Na2SO4. Removal of solvent under reduced pressure 
afforded 4-3h as an orange paste (0.2505 g crude product). 
1
H NMR (300 MHz, CDCl3) δ = 1.41 (s, 9H, 3CH3), 2.94-3.34 (m, 4H, CH2CH2), 
3.81-3.82 (s, 6H, 2OCH3), 6.56 (s, 1H, ArH); 
13
C NMR (75 MHz, CDCl3) δ = 155.8, 
153.9, 151.6, 142.6, 142.5, 141.5, 137.0, 132.5, 117.1, 117.0, 110.7, 79.0, 67.9, 59.6, 
















Compound 4-3i: an white syrup; 86% yield; 
1
H NMR (500 MHz, CDCl3) δ = 
0.80-0.96 (m, 6H, 2SnCH3), 1.42 (s, 9H, 3CH3), 2.96-3.41 (m, 4H, CH2CH2), 
3.79-3.87 (m, 6H, 2OCH3), 6.50 (s, 1H, ArH); 
13
C NMR (125 MHz, CDCl3) δ = 155.9, 
154.6, 149.8, 146.4, 130.1, 115.5, 111.3, 79.5, 56.2, 56.0, 39.9, 28.4, 28.0, 2.8. 
 














Compound 4-3j: an yellow solid; 33% yield for two steps; 
1
H NMR (300 MHz, 
CDCl3) δ = 1.40 (s, 9H, 3CH3), 2.83-3.34 (m, 4H, CH2CH2), 3.87 (s, 3H, OCH3), 3.89 
(s, 3H, OCH3), 6.83 (s, 1H, ArH); 
13
C NMR (75 MHz, CDCl3) δ = 155.7, 152.2, 143.0, 
131.7, 130.8, 127.2, 114.2, 79.3, 60.5, 56.5, 43.4, 28.5, 14.0. 
 
N-(Boc)-4-Ethylamino-6,7-dimethoxy-1,2,3-benzotrithiole 1-oxide (4-3k) and 




















A solution of 4-3j (0.1133 g, 0.2893 mmol) in CH3CN (5 mL) was irradiated 
with the wavelength of 300 nm for 4 hours. After removal of solvents by evaporation, 
the crude product was purified by flash chromatography on silica gel eluting initially 
with DCM:EA (50:1, v/v) and then with DCM:EA (10:1, v/v) to afford 4-3k (0.0227 g, 
20% yield) and 4-3l (0.0272 g, 24% yield) as light yellow solid.  
Compound 4-3k: 
1
H NMR (500 MHz, CDCl3) δ = 1.44 (s, 9H, 3CH3), 2.94-2.98 (m, 
2H, CH2), 3.44-3.45 (m, 2H, CH2), 3.91 (s, 3H, OCH3), 4.03 (s, 3H, OCH3), 6.95 (s, 
1H, ArH); 
13
C NMR (125 MHz, CDCl3) δ = 155.9, 154.7, 151.2, 143.2, 133.8, 125.0, 
116.0, 112.9, 79.5, 60.7, 56.9, 43.4, 28.5; MS (ESI) calcd for [C15H20S3NO5]
-
 M: 
390.1; found m/z 390.1. 
Compound 4-3l: 
1
H NMR (500 MHz, CDCl3) δ = 1.43 (s, 9H, 3CH3), 3.10-3.29 (m, 
2H, CH2), 3.46-3.48 (m, 2H, CH2), 3.94 (s, 3H, OCH3), 3.96 (s, 3H, OCH3), 6.78 (s, 
1H, ArH); 
13
C NMR (125 MHz, CDCl3) δ = 154.7, 151.2, 142.4, 133.8, 125.0, 116.0, 
113.0, 79.5, 60.5, 56.6, 41.4, 28.4; MS (ESI) calcd for [C15H21S3NO5Na]
+
 M: 414.1; 













Compound 4-3: an yellow solid; 94% yield; 
1
H NMR (500 MHz, CDCl3) δ = 
3.10-3.13 (m, 4H, CH2CH2), 3.93 (s, 3H, OCH3), 3.99 (s, 3H, OCH3), 7.23 (s, 1H, 
ArH); 
13
C NMR (125 MHz, CDCl3) δ = 153.1, 147.5, 137.3, 128.8, 119.9, 114.9, 62.8, 
57.53, 40.0, 35.5; HRMS (ESI) calcd for [C10H14S3NO3]
+
 M: 292.0130; found m/z 
292.0134. 
 








Compound 4-4: an yellow solid; 98% yield; 
1
H NMR (500 MHz, CDCl3) δ = 
3.26-3.33 (m, 4H, CH2CH2), 3.91 (s, 3H, OCH3), 3.94 (s, 3H, OCH3), 7.05 (s, 1H, 
ArH); 
13
C NMR (125 MHz, CDCl3) δ = 156.6, 144.3, 143.9, 142.4, 132.7, 114.9, 61.2, 
57.4, 41.5, 34.2; MS (ESI) calcd for [C10H14S3NO3]
+
 M: 292.0; found m/z 291.9; 
HRMS (ESI) calcd for [C10H14S3NO3]
+
 M: 292.0130; found m/z 292.0
 135 
Chapter 5 DNA-cleavage of Certain Assemblies G-quadruplex 
Catalyzed by Natural Amino Acid 
 
5.1 Introduction  
 
In the previous chapter, two classes of sufur-containing cyclic organic 
compounds were reported to be synthesized and both of them have shown great 
bioactivities in the thiol-dependent DNA cleavage reactions. In those reactions, pBR 
322 DNA were used. For the information of this DNA, it contains a double-stranded 
circle 4,361 base pairs in length with supercoiled topology. In fact, other 
oligonucleotides which are known as DNA fragments with genes information, can 
also show the cleavage activities when they are in certain topologies. In the following 
sections, new designed nucleotides which are stable as topology of G-quadruplex will 
be introduced to show DNA cleavage activities in the presence of natural amino acid 
and metal ions. 
DNA (Deoxyribonucleic acid) is a nucleic acid which contains the genetic 
information used in the development and functioning of all known living organisms. 
231
 From chemistry perspective, it contains two long polymers which are called 
nucleotides, together with backbones made of sugars and phosphate groups joined by 
ester bonds. These two strands of nucleotides can twist and wrap together to form a 
ladder which is called double helix structure.  
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Figure 5-1 Double helix structure of DNA 
 
There are four types of nucleobases in DNA, which are adenine (abbreviated A), 
cytosine (C), guanine (G) and thymine (T). A GC base pair is stabilized with three 
hydrogen bonds while an AT base pair is stabilized with two hydrogen bonds. These 
different bases could fit perfectly like a lock and key, which is called “Watson-Crick 





























Guanine Cytosine  
Figure 5-2 “Watson-Crick base paring” 
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Although DNA commonly exists in double helix structure by Watson-Crick base 
paring, certain guanine (G)-riched DNA four-stranded structures that are called 
G-quadruplexes.
232-235
 The basic units of G-quadruplexes are guanine tetrads which 
are shown in the Figure 5-3. Guanine tetrad is a square co-planar array of four 
guanine bases, in which each base is both the donor and acceptor of two hydrogen 
bonds with its neighbors. Positively charged metal ions can be sandwiched between 
the tetrads to stabilize the structure.  
 
Figure 5-3 Structure of guanine tetrads 
 






 Their sizes are well suited to hold the guanine quadruplex 
structure because they can efficiently coordinate the two planes of quartets which are 
lined by eight carboxyl O6 atoms from guanine. Other wide variety of cations are 
capable of occupying the central cavity of quadruplex structures,
236
 including 












The structure was known as early as 19
th
 century that quanosine and its 
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derivatives could form viscous gels in water.
237
 Until 1962, David R. Davis and 
co-workers 
238
 proposed the structure on the basis of X-ray diffraction data that four 




Besides, these ions also have great effects on the topology of guanine quadruplex 
structures. The structure of the G-quadruplex can involve just one or two telomere 
strands looping back on themselves or four separate telomere strands. In each case, 
different ions can dominate the sequence to display as parallel or disparallel form, or 
they can assemble as unimolecular, biomolecular and tetramolecular forms.  
 
Figure 5-4 Topology of G-quadruplex structure  
 
The possible biological roles for guanine quadruplex were paid little attention 
until it was elucidated in 1962 by David R. Davis. In the 1980s, the interest in guanine 
quadruplex structure was stimulated by several applications which were involved in 
the telomere protection and elongation also in the transcription regulation.
239-240
   
In addition, self-assembly of guanine-rich oligonucleotides could form 
rod-shaped liquid crystals of cholesteric and act as the scaffold of artificial ion 
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channels and ion carriers.
241-243





 are believed to rely on the formation of G-quadruplex for their 
biological actions.  
Referring to the deoxyribozymes, which also known as catalytic DNA, are DNA 
molecules with catalytic reactivity. There are no DNA molecules in nature with 
catalytic activity involved, while RNA molecules with their catalytic reactivity do 
exist. This may be because that the double helical structure of DNA with genetic 
information inside is restricted to its catalytic potential. So far, all the deoxyribozymes 
(catalytic DNA) are single stranded like single stranded RNA. The single stranded 
form of DNA makes it potential to form more specific ordered structures with 
different topology. 
Without a natural deoxyribozyme to study, much effort had been focused on 
exploring the manmade catalytic DNA, establishing its stability on some specific 
structure and discovering its catalytic reactivity like RNA or protein with enzyme 
behaviors. The first deoxyribozyme was discovered in 1994 by Ronald R. Breaker and 
Gerald Joyce at The Scripps Research Institute in La Jolla, CA.
246 
In the presence of 
divalent ion lead, the short 38 nt DNA could form the specific structure which 
promoted the RNA cleavage reaction undertaken by the mechanisium of phosphoester 
transfer. (Figure 5-5) This catalytic DNA reveals that series of metal ions combined 
with amino acids as cofactors are essential for DNA functioned as a catalyst.
245 
Catalytic amplification in this reaction is found to be 100-fold compared to the 
uncatalyzed reaction. Subsequently, some researches revealed that DNA could not 
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only act as the catalyst but also as the enzyme. It meant that deoxyribozyme could 
survive in the biological system which provided a promising environment using 
























Figure 5-5 RNA cleavage reaction by phosphoester transfer   
 
This important discovery in the field of deoxyribozyme points out a new 
direction by providing a new method to find the other deoxyribozymes. To broadening 
the reaction scope and finding more catalytic DNAs, PCR (polymerase chain reaction) 
technique was developed to create the catalytic DNA sequence by the process in vitro 
selection. This process is analogous to nature selection on an accelerated time scale. 
By processing in vitro selection, deoxyribozymes have been developed to catalyze 
many different types of reaction such as RNA cleavage, DNA cleavage, DNA 
modification and ligation, porphyrin rings metalation. Some of these deoxyribozyme 
can enhance the catalytic rate constant for their corresponding uncatalyzed reactions 
by 10 billion fold. 
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In the following paragraphs, DNA-cleaving deoxyribozyme will be mainly 
discussed based on the mechanism and its specific structure. DNA-cleaving 
deoxyribozyme is quite interesting because it involves some biological process such 
as RNA replication. Recently, two alternative mechanisms for DNA cleavage have 
been exploited by deoxyribozymes. One of the mechanisms is referred as the 
oxidation reaction.
259
 The spontaneous oxidative cleavage of DNA by hydroxyl 
radicals can be induced using redox-active metals such as Cu
2+
 and reducing agents 
such as ascorbate.
259-260
 Another mechanism of DNA cleavage is followed by a 
site-specific depurination process.
261
 However by oxidative mechanism or 
depurination process, a nucleotide could be eliminated from the target DNA chain 
during the cleavage process, and in turn the elimination process will finally result in 
the loss of sequence-encoded information.  
In order to overcome this shortcoming, hydrolysis of phosphate ester bond may 
be considered as an attractive method since in the DNA cleavage reaction, no genetic 
information is lost in this process. But this is very challenging because of the natural 
property of DNA. The absence of 2‟-hydroxyl groups makes DNA approximately 105 
times more resistant to hydrolysis compared to the rate constant of the related internal 
RNA transesterification reaction.
262
 However, this functional limitation can be 
overcome by utilizing the metal ions combined natural amino acid, plus varying of 
DNA structures. The metal ions combined with natural amino acid could partially 
neutralize the negative charge of backbones of single stranded DNA and coordinate 
with water to carry out the acid/base catalysis for phosphodiester bond hydrolysis.  
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And the specific topology of single stranded DNA, especially G-quadruplex 
structures have been proved to be crucial in maintaining the reactivity of 
deoxyribozyme such as porphyrinmetalating deoxyribozyme, HD RNA-cleaving 
DNA enzyme and ATP-utilizing kinase deoxyribozyme.  
So based on the previous cases reported and mechanisms involved inside, it 
becomes possible to explore of DNA cleavage reaction by direct hydrolysis of a 
phosphoester bond based on G-quadruplex structure catalyzed by natural amino acid 
combined with metal ions. This type of reaction has never been explored in previous 
work mainly because of the extraordinarily slow background rate of hydrolytic 
cleavage of DNA. Although the reaction is very challenging, if this reaction can be 
proved, this will be the first study to report this type of reaction. It may also provide 
the basis for further research in the vitro process to see whether this is suitable for 
using as an anticancer drug candidate.  
The overall objective of this project is to search and confirm the deoxyribozymes 
based on the G-quadruplex catalyzed by natural amino acid combined with metal ions 
and the specific aims are: 
(1) To develop the DNA sequences based on the different topology of 
G-quadruplex. 
(2)  To confirm the site-specific DNA cleavage by different methods such as 
PAGE, CD and Mass.  
(3)  To optimize the reaction conditions and consider the factors which will 
affect the reaction greatly. These factors could be: pH value, DNA 
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concentration, metal ions and etc. 
So in the following sections, site specific cleavage reaction of a guanine-riched 
oligonucleotide is thoroughly studied during the investigation. Subsequent 
examinations on certain factors are described, such as variation of metal ions, pH 
values and concentration of DNA. In addition, kinetic analysis of self-cleavage of 
G-quadruplex is also carried out. Last methods and materials are also included.  
 
5.2 Results and Discussion 
5.2.1 Emergence of Self-cleavage Activity 
Besides the physical and chemical properties of G-quadruplex described 
previously, certain assemblies of G-quadruplex could also perform self-cleaving 
action in site specific fashions catalyzed by natural amino acid combined with metal 
ions.   
A schematic diagram of a DNA self-cleavage processes uncovered during recent 
investigations is depicted in Figure 5-6. A guanine-rich 30-mer oligonucleotide 
(Oligonucleotide 1 in Figure 5-6) was designed previously in our laboratory with the 
expectation that this oligonucleotide would form an externally looped G-quadruplex 
assembly (a in Figure 5-6) under proper conditions. The initial intention in designing 
such a guanine-rich oligonucleotide was to examine whether a transesterification 
reaction could be feasible between the hydroxyl group at its 3‟ end and the 
phosphodiester bond between A16 and G17 since these functional groups are proximal 
to each other upon G-quadruplex formation. Instead of observing such a designed 
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transesterification reaction, a selfcleavage reaction of Oligonucleotide 1 at one of the 




























































Oligonucleotide 1 Fragment 1 Fragment 2
Oligonucleotide 1: 5' T1G2GGGTTAGGGGAA14A15AGGTTAGGGGTTAG29G30 3' (30-mer)
Fragment 1: 5' T1G2GGGTTAGGGGA13A14 3' (14-mer)
Fragment 2: 5' p-A15A16GGTTAGGGGTTAG29G30 3' (16-mer)




Figure 5-6 Schematic representation of a self-cleavage process of Oligonucleotide 1 
uncovered in these studies  
 
Oligonucleotide 1 was accordingly phosphorylated at its 5‟ end with [γ-32P] ATP 
in the presence of T4 polynucleotide kinase and further purified by polyarylamide gel 
electrophoresis and gel filtration chromatography in the studies. In order to allow the 
formation of proper G-quadruplex assemblies, this guanine-rich oligonucleotide was 
next incubated at 20 
0
C in the presence of 5 mM NaCl for 12 hours followed by 
addition of KCl (final concentration 5 mM), which was then kept at the same 
temperature for additional 12 hours. The self-cleavage reactions of Oligonucleotide 1 
were initiated next by adding a premixed solution of MgCl2 and histidine to the 
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mixture, which was further kept at 34 
0
C for a different period of time. As shown in 
Figure 5-7, a new fast moving band was observed when such a reaction was allowed 
to proceed for 2 hours (Band 1 in Lane 3). The mobility shift of this new band is close 
to that of a molecular weight marker of 14-mer (5‟ *p-TGGGGTTAGGGGAA 3‟, 
Lane 5), which implied that a cleavage reaction took place between A14 and A15 of this 
guanine-rich sequence. 
 
                                    
               Lane   1   2    3    4   5    6 
 
Figure 5-7 Polyacrylamide gel electrophoretic analysis of self-cleavage of DNA visualized by 
autoradiography. Lane 1: Oligonucleotide 1 alone; Lanes 2 to 3: self-cleavage reactions lasting for 
0 and 2 h respectively; Lane 4: a 15-mer Oligonucleotide (*p-TGGGGTTAGGGGAAA) alone; 
Lane 5: a 14-mer (*p-TGGGGTTAGGGGAA) alone; Lane 6: a 13-mer 
(*p-TGGGGTTAGGGGA) alone.  
 
5.2.2 Confirmation of Self-Cleaving Action of a Particular G-quadruplex 
If a DNA cleavage reaction indeed occurred in the middle of the sequence of 
Oligonucleotide 1, a second fragment of 16-mer should in theory be generated at the 
same time. In order to visualize the two fragments of 14-mer and 16-mer (Fragment 1 
and Fragment 2 shown in Figure 5-6) simultaneously, the experiment of methylene 
Band 1 
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blue staining was conducted next.  
Lane           1    2    3     4    5      6     7 
                    
Figure 5-8 Polyacrylamide gel electrophoretic analysis of self-cleavage of DNA visualized by 
methylene blue staining.  The same procedures as those for preparing samples loaded in Lane 3 
was used except that 5‟ 32P-labeled Oligonucleotide 1 was replaced with 5‟ hydroxyl 
Oligonucleotide 1 and methylene blue staining protocol was adopted for visualizing the DNA 
bands.  Lane 1: Oligonucleotide 1 alone; Lane 2: self-cleavage reaction lasting for 2 hr. Lane 3: a 
17-mer (5‟ AAAGGTTAGGGGTTAGG 3‟) alone; Lane 4: a 16-mer (5‟ 
AAGGTTAGGGGTTAGG 3‟) alone; Lane 5: a 15-mer (5‟ TGGGGTTAGGGGAAA 3‟) alone; 
Lane 6: a 14-mer (5‟ TGGGGTTAGGGGAA 3‟) alone; Lane 7: a 13-mer (5‟ 
TGGGGTTAGGGGA 3‟) alone. 
 
As shown in Figure 5-8, two fast moving bands (Band 1 and Band 2 in Lane 2) 
were visible from the stained polyacrylamide gel, which displayed the same mobility 
shifts as those of a 14-mer marker (Lane 6) and a 16-mer marker (Lane 4) 
respectively. These electrophoretic analysis data are indications that a cleavage 
reaction indeed took place between A14 and A15 in the middle of the sequence of 







5.2.3 Confirmation of Self-Cleaving Action at specific site 
Oligonucleotide 1 that contains radiolabeled phosphorus (
32
P) between A14 and 
A15 (5‟ TGGGGTTAGGGGAA-
32
p-AAGGTTAGGGGTTAGG 3‟, internally 
32
P-labeled Oligonucleotide 1) was next synthesized and examined during the 
investigations in order to determine which of the two fragments possesses the 
phosphate group.  
As shown in Figure 5-9, the only observable self-cleavage product from the 
internally 
32
P-labeled Oligonucleotide 1 is a 16-mer fragment (5‟ 
*p-A15AGGTTAGGGGTTAGG30 3‟) while not even a trace amount of 14-mer (5‟ 
T1GGGGTTAGGGGAA14-*p 3‟) is detectable, which is the sign that the phosphate 
group goes exclusively along with the 16-mer fragment rather than with the 14-mer as 
illustrated in Figure 5-6. 
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     Lane     1     2    3      4      5     6      7 
 
Figure 5-9 Polyacrylamide gel electrophoretic analysis of internally 
32
P-labeled Oligonucleotide 1 
(5‟ TGGGGTTAGGGGAA-32p-AAGGTTAGGGGTTAGG 3‟) in its self-cleavage reactions. 
Lane 1: internally 32P–labeled Oligonucleotide 1 alone; Lane 2 to 3: self-cleavage reactions 
lasting for 0 and 2 hr; Lane 4: a 17-mer (5‟ *p-AAAGGTTAGGGGTTAGG 3‟) alone; Lane 5: a 
16-mer (5‟ *p-AAGGTTAGGGGTTAGG 3‟) alone; Lane 6: a 15-mer (5‟ 
*p-AAGGTTAGGGGTTAGG 3‟) alone; Lane 7: a 14-mer (5‟ *p-TGGGGTTAGGGGTT 3‟).  
 
In addition, the oligonucleotide fragment in Band 1 in Lane 3 in Figure 5-9 was 
purified and further analyzed through hydrolysis by exonuclease I, an enzyme that 
digests single-stranded DNA in a 3‟ to 5‟ direction in a stepwise fashion. As shown in 
Figure 5-10, the purified 
32
P-containing oligonucleotide fragment was completely 
degraded in the presence of the single strand-specific nuclease (Lane 3), which could 
be taken as an indication that this oligonucleotide fragment (Fragment 2 in Figure 




Figure 5-10 Hydrolysis of Fragment 2 (see Figure 5-6 for its sequence information) generated in 
theself-cleavage reaction of Oligonucleotide 1 by exonuclease I. The oligonucleotide fragment in 
Band 1 in Lane 3 in Fig. 5 was cut out, eluted and further purified using gel filtration 
chromatography (NAP-25, GE Healthcare). A mixture (40 μL) containing 1 x exonuclease I buffer, 
the purified 32P-containing oligonucleotide fragment (Fragment 2) and 5 units of exonuclease I 
was incubated next at 37 
o
C for 30 min. Lane 1: Fragment 2 alone; Lane 2: a reaction mixture 
containing no exonuclease I and Lane 3: a reaction mixture containing 5 units of exonuclease I. 
 
Based on the above observations, it can be suggested that the self-cleaving 
reaction of Oligonucleotide 1 took place at one of the phosphodiester bonds near the 
3‟ end of A14 in the middle of its sequence as illustrated in Figure 5-11. Nevertheless, 
more direct evidence is evidently needed to further verify this suggested mechanism 
in the future. 
 
Figure 5-11 Diagrammatic illustration of a possible self-cleaving reaction at one of 
the two phosphodiester bonds between AB14B and AB15B of Oligonucleotide 1 
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5.2.4 Reaction Parameters of the DNA Cleavage Reaction  
5.2.4.1 Time Dependence 
In addition, the time dependent self-cleavage reactions were examined in the 
studies. As shown in Figure 5-12, the yield of the self-cleavage reactions increased 
with the increasing reaction time and ~50% cleavage of Oligonucleotide 1 could be 
achieved within ~2 hours. 
Time (h)   0     0.5   1   2    3    4      -   - 
Lane     1     2     3   4    5    6    7      8 
       
Figure 5-12 Time dependence of self-cleavage reaction of Oligonucleotide 1. The same 
procedures as those for preparing samples loaded in Lane 3 in Figure 2 were used except that the 
reactions were stopped at different time intervals. Lane 7: Oligonucleotide 1 alone; Lane 8: a 
14-mer (*p-TGGGGTTAGGGGAA) alone.  The time of reaction in Lanes 1, 2, 3, 4, 5 and 6 








5.2.4.2 Ion Dependence  
With the aim of verifying that G-quadruplex structure could be formed by 
Oligonucleotide 1 as anticipated, CD spectroscopic analysis on a solution containing 
this guanine-rich sequence was also carried out.  As shown in Figure 5-13, this 
Oligonucleotide 1-containing solution displayed a maximum absorption at 295 nm, 
which is a characteristic sign of the presence of anti-paralleled G-quadruplex 
structures in the mixture. 
263-264
 Potassium ion is, on the other hand, known to be one 




















Figure 5-13 CD spectroscopic analysis of Oligonucleotide 1. A mixture (pH 7.0) containing 5 
mM HEPS, 5 mM NaCl, 5 mM KCl and 10 μM Oligonucleotide 1 was examined with a CD 
Spectropolarimeter at 34 oC (black) and 90 oC (red) respectively over an range of wavelengths 
from 220 nm to 330 nm.  
 
5.2.4.3 Potassium Ion Concentration Dependence 
As a comparison, additional self-cleavage reactions of Oligonucleotide 1 were 
carried out in our studies in which the concentration of potassium ion varied. As 
shown in Fig. 5-14, there was no DNA cleavage detectable when potassium ion was 
 152 
absent from the corresponding reaction mixture (Lane 2). This observation is 
consistent with the suggestion that formation of stable G-quadruplex is a prerequisite 
for the self-cleavage reaction of Oligonucleotide 1.  
 
Figure 5-14 Effect of potassium ion concentration on the self-cleavage reaction of 
Oligonucleotide 1. The same procedures as those for preparing samples loaded in Lane 3 in Fig. 2 
were used except that concentration of potassium chloride in the new experiments varied. Lane 1: 
Oligonucleotide 1 alone; Lane 2: 0 mM KCl; Lane 3: 2.5 mM KCl; Lane 4: 5 mM KCl; Lane 5: 
10 mM KCl and Lane 6: 20 mM KCl. 
 
5.2.4.4 Temperature Dependence 
Furthermore, the temperature dependence of the self-cleavage reactions of 
Oligonucleotide 1 was examined during our investigations. It appeared that the 
self-cleaving reactivity of this oligonucleotide was lost completely when the 
temperature of the corresponding reaction increased to 45 
o
C (Lane 7 in Figure 5-15), 




Figure 5-15 Temperature dependence of self-cleavage reactions of Oligonucleotide 1.The same 
procedures as those for preparing samples loaded in Lane 3 in Fig. 2 were used except that the 
new reaction mixtures were incubated at different temperatures. Lane 1: Oligonucleotide 1 alone. 













C and 45 C respectively. 
 
5.2.4.5 Sequence Dependence 
Two new guanine-rich oligonucleotides were further designed during our 
investigations that contain the same sequences as Oligonucleotide 1 except that one or 
two guanines are replaced with non-guanine nucleotides (Oligonucleotide 2 and 
Oligonucleotide 3 in Table 5-1).  
 
Table 5-1 Guanine-rich oligonuelotides that were examined I our studies 
(a) Oligonucleotide 1: 
5‟ TGGGGTTAGGGGAAAAGGTTAGGGGTTAGG 3‟ 
(b) Oligonuelotides that contain one and two “mismatched” guanines.  
Oligonucleotide 2:  
5‟ TGGCGTTAGGGGAAAAGGTTAGGGGTTAGG 3‟ 
Oligonucleotide 3: 
5‟ TGGCGTTAGAGGAAAAGGTTAGGGGTTAGG 3‟ 
 154 
(c) Oligonuleotides that contain alternative nucleotides in the loops appearing at the 
ends of their columnar structures. 
Oligonucleotide 4: 
5‟ TGGGGTTAGGGGAAAAGGTTTGGGGTTAGG 3‟ 
Oligonucleotide 5: 
5‟ TGGGGTTAGGGGAAAAGGTTTTGGGGTTAGG 3‟ 
(d) Oligonucleotides that contain five and three consecutive adenosines in their side 
loops. 
Oligonucleotide 6: 
5‟ TGGGGTTAGGGGAAAAAGGTTAGGGGTTAGG 3‟ 
Oligonucleotide 7: 
5‟ TGGGGTTAGGGGAAAGGTTAGGGGTTAGG 3' 
 
These two new oligonucleotides are in theory unable to form ordinary 
G-quadruplex structures due to the presence of „mismatched‟ guanine bases. It turned 
out that neither of these two mismatched sequences displayed a detectable 
self-cleaving activity under our standard reaction conditions (Lane 4 and Lane 6 in 
Figure 5-16).  
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Figure 5-16 Sequence dependence of self-cleavage reaction of G-quadruplexes. The same 
procedures as those for preparing samples loaded in Lane 3 in Fig. 2 were used except that 
Oligonucleotide 1 was replaced with Oligonucleotide 2, Oligonucleotide 3, Oligonucleotide 4, 
Oligonucleotide 5, Oligonucleotide 6 and Oligonucleotide 7 (see Table S1) respectively. Lane 1 
and Lane 2: reactions of Oligonucleotide 1 lasting for 0 and 120 min respectively; Lane 3 and 
Lane 4: reactions of Oligonucleotide 2 (5‟ TGGCGTTAGGGGAAAAGGTTAGGGGTTAGG 3‟) 
lasting for 0 and 120 min respectively; Lane 5 and Lane 6: reactions of Oligonucleotide 3 (5‟ 
TGGCGTTAGAGGAAAAGGTTAGGGGTTAGG 3‟) lasting for 0 and 120 min, respectively; 
Lane 7 and Lane 8: reactions of Oligonucleotide 4 (5‟ 
TGGGGTTAGGGGAAAAGGTTTGGGGTTAGG 3‟) lasting for 0 and 120 min respectively; 
Lane 9 and Lane 10: reactions of Oligonucleotide 5 
(5‟TGGGGTTAGGGGAAAAGGTTTTGGGGTTAGG 3‟) lasting for 0 and 120 min 
respectively. 
 
However, when alterations of nucleotides in some loops located at the ends of 
the columnar structure of Oligonucleotide 1 were made, the resulting oligonucleotides 
(Oligonucleotide 4 and Oligonucleotide 5 in Table 5-1) still exhibited self-cleaving 
activity (Lanes 8 and 10 in Figure 5-17). These observations could be indications that 
Oligonucleotide 1 relies on the formation of a G-quadruplex structure for its 
self-cleaving activity. 
As a comparison with Oligonucleotide 1 which possesses four consecutive 
adenosines in the middle of its sequence, new G-quadruplex structures containing five 
and three adenosines in a row (Oligonucleotides 6 and 7 in Table 5-1) in the loop 
located at the sides of their columnar structures were also designed and examined.  
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As shown in Figure 5-17, the self-cleavage rate of Oligonucleotide 6 (a five 
adenosine containing structure) was close to that of Oligonucleotide 1 (Lane 6) while 
there was no self cleavage product observable (Lane 2) when the size of its side loop 
was reduced to three consecutive adenosines (Oligonucleotide 7). These results 
suggest that besides the formation of a G-quadruplex assembly, the geometry of the 
side loop within the tetraplex columnar structure plays certain crucial roles in the site 
specific self DNA cleaving processes. 
 
Figure 5-17 Effect of side loop variation on the self-cleaving reactivity of G-quaduplex structures. 
The same procedures as those for preparing samples loaded in Lane 3 in Fig. 5.2.1.2 were used 
except that Oligonucleotide 1 was replaced by Oligonucleotide 6 and Oligonucleotide 7 
respectively. Lane 1 and Lane 2: reactions of Oligonucleotide 7 (5‟ 
TGGGGTTAGGGGAAAGGTTAGGGGTTAGG 3‟) lasting for 0 and 120 min respectively; Lane 
3 and Lane 4: reactions of Oligonucleotide 1 lasting for 0 and 120 min respectively; Lane 5 and 
Lane 6: reactions of Oligonucleotide 6 (5‟ TGGGGTTAGGGGAAAAAGGTTAGGGGTTAGG 
3‟) lasting for 0 and 120 min respectively. 
 
5.3 Conclusion 
This chapter described a new deoxyribozyme which could undergo the DNA 
self-cleavage reaction based on guanine quadruplex structure catalyzed by the 
combination of Mg
2+
 and histidine. It was proved that a new DNA sequence was 
found based on the topology of G-quadruplex. The CD spectrum shows that the 
G-quadruplex structure is definitely formed in the presence of the K
+
 ions. The curve 
indicates that this structure is most likely formed as a parallel topology because it has 
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a characterized peak at 298 nm which is an indication of parallel structure. Although 
such a guanine-rich oligonucleotide (Oligonucleotide 1) is designed for the 
transesterification reaction initially, it was unexpected to discover this self-cleavage 
reaction between the loop of the hydroxyl group at its 3‟ end and the phosphordiester 
bond between A16 and G17 in this sequence of Oligonucleotide 1. 
In addition, other oligonucleotides analogues with various lengths of loops based 
on the G-quadruplex could also undergo the self-cleavage reactions. This fact 
suggests that as long as the G-quadruplex structures form at the specific topology, the 
reaction can occur at the proper condition. This finding has provided valuable insight 
that G-quadruplex is a crucial structure for some deoxyribozymes as a catalyst and 
this tetraplex assembly has its unique spatial arrangement as well as its functionality 
in the biological process. 
This chapter also examined the self-cleavage reaction of DNA based on 
G-quadruplex by the process of hydrolysis of phosphordiester bond. Many different 
methods were developed to confirm the site-specific DNA cleavage by different 
methods such as PAGE, CD and Mass spectrum. Phosphorus (
32
P) is radiolabeled in 
the Oligonucleotide 1 between A14 and A15 (5‟ 
TGGGGTTAGGGGAA-
32
P-AAGGTTAGGGGTTAGG 3‟) and it was proved by 
comparing the marker that the phosphate group went exclusively along with the 
16-mer fragment. This was also proved by the methylene blue staining which showed 
both 16-mer and 14-mer fragment in the gel. In addition, the hydrolysis of the process 
was suggested by the TOF- Mass spectrum. The spectrum showed the exact molecular 
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weight of the product after the self-cleavage reaction. It reveals that the product 
contains the phosphor group which indicates that the reaction can only occur in the 
way of hydrolysis. Compared to other mechanisms such as oxidative mechanism or 
depurination process, hydrolysis has obvious advantages over other mechanisms. The 
nucleotide is not eliminated from the target DNA chain during the cleavage process, 
and in turn the elimination process does not loss the sequence-encoded information 
which is very important in the biological process. Although DNA hydrolysis is much 
difficult because of the absence of 2‟-hydroxyl groups in the DNA, this is the first 
study to report that the self-cleavage reaction can be carried out by the hydrolysis 
process. It has provided a new perspective that it is possible to have reaction occure in 
a hydrolysis way only if the G-quadruplex structure is formed with specific topology. 
It also shed light on searching of other new types of deoxyribozymes which could 
perform the cleavage reaction. 
Thirdly, to optimize the reaction conditions, many reaction factors were also 
investigated one by one. These factors were: metal ions, DNA concentration and pH 
value. For the Metal ion dependence of the reaction, the result shows that potassium 
ion is required in this DNA-cleaving reaction. This has been well established by the 
references compared to the preference of monovalent ions by G-quadruplex. The 










. For the DNA concentration dependance 
of the reaction, the result indicates that it is necessary that the concentration of 
Oligonucleotide 1 is higher than 100 nM. This is most likely due to a different 
template of G-quadruplex generated before the cleavage course under high 
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concentration of Oligonucleotide 1. Also for the pH dependence of the reaction, the 
variation of pH values has little effect on the stability of G-quadruplex, the high yield 
product of the self-cleavage reaction of Oligonucleotide 1 could be obtained at pH 
range of 7.5 to 6.5 which is more favorable to the catalytic process. All the factors 
which are fully investigated help us know more about the reaction condition of the 
reaction. It provides much efficient data and these data could be very useful for other 
researchers to explore this type of reaction further. 
In summary, Self-cleavage reaction of a guanine-riched oligonucleotide 
(Oligonucleotide 1) was thoroughly studied during the investigation. It appeared that 
the presence of potassium ions is a prerequisite for the self-cleavage reaction. The 
results of the studies are consistent with the suggestion that G-quadruplex is the core 
structure needed for the self-cleavage process by hydrolysis.  
However, further applications of this reaction are discussed in less detail in this 
thesis because this is only the first example in self-cleavage reaction based on the 
G-quadruplex structure by hydrolysis mechanism. Although many researches have 
shown the importance of G-qudruplex in the biological process, there is still not 
enough knowledge about the role of the DNA self-cleavage reaction in biological 
system. So there is still long way to apply the reaction to the real biological system  
To further extend the research, the terometic repeated G-quadruplex could be 
used to test the self-cleavage reaction because the structure is similar to the 
Oligonucleotide 1 and it is more close to the real sequence of DNA in the cell. 
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5.4 Materials and Methods 
5.4.1 Oligonucleotides  
All oligonucleotides used in our studies are purchased from Sigma-Proligo 
(Singapore) which provided custom oligonucleotides synthesis. Oligonucleotides are 
usually supplied as a lyophilized power that could be disolved in water and diluted to 
suitable concentration for reactions. All oligonucleotides samples should be stored at 
– 20 °C. Common synthetic oligonucleotides are provided with 5‟ end hydroxyl group 
which is suitable for 5‟ end labeling reactions.  
 
5.4.2 Kinase 
T4 DNA ligase used in our studies is purchased from New England Biolabs (Cat. 
Number: M0202L, 100,000 units per package, 400 units/μL in 10 mM Tris-HCl, 50 
mM KCl, 1 mM DTT, 0.1 mM EDTA and 50% Glycerol, pH 7.4 @ 25 °C). The 
enzyme should be stored at -20 °C. 
T4 DNA ligases catalyze the formation of a phosphodiester bond between 5' 
phosphate and 3' hydroxyl termini in duplex DNA or RNA. This enzyme will join 
blunt end and cohesive end termini as well as repair single stranded nicks in duplex 
DNA, RNA or DNA/RNA hybrids. 
One unit of T4 DNA ligase gives 50% ligation of HindIII fragments of λ DNA 
(5´ DNA termini concentration of 0.12 μM, 300 μg/ml) in a total reaction volume of 
20 μl in 30 minutes at 16 °C in 1x T4 DNA Ligase Reaction Buffer. The enzyme can 
also catalyze the ligation at room temperature. For cohesive ends, use 1 μl of T4 DNA 
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Ligase in a 20 μl reaction for 10 minutes. For blunt ends, use 1 μl of T4 DNA Ligase 
in a 20 μl reaction for 2 hours or 1 μl high concentration T4 DNA Ligase for 10 
minutes. The enzyme was supplied with 10 x reaction buffer (0.5 M Tris-HCl, 100 
mM MgCl2, 10 mM ATP, 100 mM Dithiothreitol, pH 7.5 @ 25°C). 
 
5.4.3 Buffer and Solution 
L-Histidine, sodium chloride solution, potassium chloride solution, magnesium 
chloride solution, HEPES and HEPES buffer were purchased from Sigma while all 
oligonucleotides used in these studies were purchased from Sigma-Proligo. 
a) TBE buffer 
TBE buffer used in our studies are purchased from 1st Base Pte Ltd. (Cat.Number: 
3010-10 x 1L, 1L per package). It is supplied in 10 times concentration solution 
which contains 1M Tris, Borate Acid and EDTA (pH 8.3). 
b) TAE buffer 
TAE buffer used in our studies are purchased from 1st Base Pte Ltd. (Cat.Number: 
3000-10 x 1L, 1L per package). It is supplied in 10 times concentration solution 
which contains 1M Tris, Acetate Acid and EDTA (pH 8.0). 
c) Tris-HCl 
Tris-HCl buffer used in our studies are purchased from 1st Base Pte Ltd. 
(Cat.Number: 1415 -1L, 1L per package, contains 1M Tris (pH 7.0). 
d) MES 
MES used in our studies are purchased from Sigma-Aldrich (Cat. Number: 
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M3671-50G) in solid state. It was dissolved in deionized water at desired 
concentration and adjusted to appropriate pH value by using 1M NaOH or 1M HCl. 
e) HEPES 
HEPES used in our studies are purchased from Sigma-Aldrich (Cat. Number: 
H3375-25G) in solid state. It was dissolved in deionized water at desired 
concentration and adjusted to appropriate pH value by using 1M NaOH or 1M HCl. 
 
5.5 Methodology 
5.5.1 5’ End Labeling of DNA  
End labeling is a rapid and sensitive method in visualizing small amount of DNA. 
It provides 3‟ End labeling and 5‟ end labeling onto 3‟ or 5‟ end of target sequences 
via enzyme catalytic reaction respectively.  
Compare to the rapidly developed nonradioactive method, radioactive labeling is 
still our first choice because 1) High sensitivity, only trace amount of molecules need 
to be detected; 2) Same chemical and physical properties were provided in end 
labeling. The material for the labeling reaction was conducted as following described: 
5‟ hycroxyl oligonucleotide (100 μM) 2 μL 
10 x reaction buffer 2 μL 
T4 PNK (10 units/ μL) 1 μL 
[γ-32P] ddATP (10 μCi/ μL ) 2 μL 
H2O 2 μL 
10 x reaction buffer including: 0.7 M Tris-HCl, pH 7.6, 100 mM MgCl, 50 mM 
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Dithiothreitol. 
The reaction mixture was incubated at 37 °C for 1 hour and 10 μL denaturing 
loading buffer was added before loading on a 20% (19:1) denature PAGE for further 
purification. 
 
5.5.2 Polyacrylamide Gel Electrophoresis (PAGE) 
Two types of polyacrylamide gels are in common use: One is non-denaturing 
polyacrylamide gel for the separation and purification of oligonuleotides without 
destroying their tertiary structures while denaturing polyacrylamide gel does in the 
other way. Preparations of denaturing and non-denaturing gels are similar and the 
only difference is that denaturing gels needs urea while non-denaturing gels don not. 
The materials for preparing these gels are as following: 
Acrylamide 190 g 
N,N‟-methylenebisacrylamide 10 g 
10 x TBE buffer 100 mL 
Urea 420 g 
H2O  
To 1 L 20% acrylamide solution was prepared via dissolving these materials 
described in H2O. The solution may be stored at 4 °C for several weeks. Place the 
required quantity of acrylamide solution in a clean beaker. Add 30 μL of TEMED 
(N,N,N‟,N‟-tetramethylethylenediamine) to acrylamide solution, then 500 μL 10% 
(w/v) ammonium persulfate water solution. Mix the solution by stirring. Pour into the 
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gel plate. The gel will be solidified in 15 minnutes. 
 
5.5.3 DNA Purification 
Purifications of oligonucleotides are needed in all reactions. They can be eluted 
from gel and dissolve in buffer solutions. Various of methods have been developed 
for the purification of DNA, such as dialysis, ion-exchange and solid phase extraction. 
a) Solid phase extraction 
C18 cartridge (WAT023590) can be used in the solid phase extraction with all 
kinds of solvents. It was activated by washing 500 μL CH3CN for two times, followed 
by 500 μL H2O and lastly loaded with the desired buffer which was 500 μL 1M 
Tris-HCl pH 7.0 buffer in the reaction. The oligonucleotides solution was 
subsequently loaded to the cartridge. Then it was washed with 500 μL water for 3-5 
times and eluted from column by 500 μL CH3CN/H2O (1:1 v/v). The purified 
oligonucleotides were collected drop by drop and dried in the sample vials. 
 
b) Ion-exchange purification 
To purify the radio-labeled oligonucleotides, NAP-25 columns from GE 
Healthcare can be used. The columns are pre-packed with Sephadex G-25 DNA 
Grade in distilled water (which contains 0.15% Kathon CG/ICP Biocide, used as a 
preservative). 
They are designed for the rapid and efficient desalting, buffer exchange and 
purification of DNA and oligonucleotides (equal or greater than 10 mers) utilizing 
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gravity flow. The maximum sample volume for purification is 2.5 ml, and the volume 
of eluted sample is 3.5 ml. The columns should be equilibrated with 25 ml 10 mM 
sodium phosphate buffer (pH 6.8) first. After equilibrated, 2.5 ml and additional 3.5 
ml of equilibration buffer is then added in twice to elute the sample. 1.5 ml of solution 
containing the oligonucleotides can be collected then and dried in the sample vials. 
 
5.6 Presentative Procedures for DNA Cleavage Reaction   
 
5.6.1 Detailed Procedures for Polyacrylamide Gel Electrophoretic Analysis of 
Self-cleavage of DNA Visualized by Autoradiography 
Oligonucleotide 1 was labeled with [γ-32P] ATP at its 5‟ end in the presence of 
T4 polynucleotide kinase followed by purification via polyacrylamide gel 
electrophoresis (20 %). The slice of band containing 
32
P-labled Oligonucleotide 1 was 
cut out from the polyacrylamide gel and kept at an elution buffer (5 mM HEPES, pH 
7.0, 5 mM NaCl and 5 mM histidine) for 3 hour followed by purification with gel 
filtration chromatography (NAP-25, GE Healthcare) eluted with the same elution 
buffer. The obtained Oligonucleotide 1 (~20 nM) in 5 mM HEPES (pH 7.0), 5 mM 
NaCl and 5 mM histidine was then kept at 20 
o
C for 12 hr. KCl was then added and 
the resultant solution was further adjusted to contain in 5 mM HEPES (pH 7.0), 5 mM 
NaCl, 5 mM KCl, 5 mM histidine and ~10 nM Oligonucleotide 1, which was further 
maintained at 20 
o
C for additional 12 hr. Self-cleavage reactions of Oligonucleotide 1 
was initiated next by mixing a premixed solution of MgCl2 and L-histidine with other 
reaction components and the resultant mixture [5 mM HEPES (pH 7.0), 5 mM NaCl, 
5 mM KCl, 10 mM MgCl2, 5 mM L-histidine and ~5 nM Oligonucleotide 1] was 
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further kept at 34 
0
C for different time periods. The self-cleavage reaction products 
were analyzed via 20% polyacrylamide gel electrophoresis after the reactions were 
stopped by addition of loading buffers followed by placing the reaction mixtures on 
ice. 
 
5.6.2 Detailed Procedures for Polyacrylamide Gel Electrophoretic Analysis of 
Internally 
32
P-labeled Oligonucleotide 1 in the Self-cleavage Reactions 
A 16-mer oligonucleotide (5‟AAGGTTAGGGGTTAGG 3‟) was labeled with 
[γ-32P] ATP at its 5‟ end in the presence of T4 polynucleotide kinase. The purified 5‟ 
phosphorylated 16-mer was further ligated with a 14-mer (5‟ TGGGGTTAGGGGAA 
3‟) on the template of 5‟ CCTAACCTTTTCCCCTAA 3‟ in the presence of T4 DNA 
ligase. The produced internally 
32
P labeled Oligonucleotide 1 was further purified 
with polyacrylamide gel electrophoresis (20 %) and gel filtration chromatography 
(NAP-25, GE Healthcare). The same procedures as those for preparing samples 
loaded were further carried out except that 5‟ 32P-labeled Oligonucleotide 1 was 
replaced with the internally 
32
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